Detection	O
of	O
the	O
chromosome	B-RNA
16	I-RNA
CBF	I-RNA
beta-MYH11	I-RNA
fusion	I-RNA
transcript	I-RNA
in	O
myelomonocytic	O
leukemias	O
.	O

Karyotypic	O
detection	O
of	O
chromosomal	O
16	O
abnormalities	O
classically	O
associated	O
with	O
AML	O
M4Eo	O
can	O
be	O
difficult	O
.	O

Characterization	O
of	O
the	O
two	O
genes	O
involved	O
in	O
the	O
inv	O
(	O
16	O
)	O
(	O
p13q22	O
)	O
,	O
CBF	B-DNA
beta	I-DNA
and	O
MYH11	B-DNA
,	O
has	O
allowed	O
the	O
detection	O
of	O
fusion	B-RNA
transcripts	I-RNA
by	O
reverse-transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
)	O
.	O

We	O
have	O
analyzed	O
CBF	B-RNA
beta-MYH11	I-RNA
fusion	I-RNA
transcripts	I-RNA
by	O
RT-PCR	O
in	O
myelomonocytic	O
leukemias	O
,	O
with	O
or	O
without	O
eosinophilia	O
,	O
to	O
determine	O
whether	O
their	O
presence	O
correlates	O
with	O
morphology	O
.	O

Fifty-three	O
cases	O
(	O
11	O
AML	O
M4Eo	O
;	O
1	O
AML	O
M4	O
with	O
atypical	B-cell_type
abnormal	I-cell_type
eosinophils	I-cell_type
(	O
AML	O
M4	O
``	O
Eo	O
''	O
)	O
;	O
29	O
AML	O
M4	O
;	O
8	O
AML	O
M5	O
;	O
3	O
CMML	O
;	O
and	O
1	O
AML	O
M2	O
with	O
eosinophilia	O
)	O
were	O
analyzed	O
.	O

All	O
11	O
typical	O
AML	O
M4Eo	O
were	O
CBF	B-DNA
beta	I-DNA
-MYH11	B-DNA
positive	O
.	O

The	O
single	O
case	O
of	O
AML	O
M4	O
with	O
distinctive	O
eosinophil	O
abnormalities	O
was	O
negative	O
by	O
karyotype	O
,	O
RT-PCR	O
and	O
fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
.	O

Three	O
of	O
29	O
(	O
10	O
%	O
)	O
AML	O
M4	O
without	O
abnormal	B-cell_type
eosinophils	I-cell_type
were	O
CBF	B-DNA
beta	I-DNA
-MYH11	B-DNA
positive	O
,	O
1	O
of	O
which	O
did	O
not	O
show	O
any	O
apparent	O
chromosome	B-DNA
16	I-DNA
abnormalities	O
by	O
classical	O
metaphase	O
analysis	O
(	O
2	O
not	O
tested	O
)	O
.	O

Both	O
cases	O
tested	O
also	O
showed	O
MYH11	B-DNA
genomic	O
rearrangement	O
.	O

None	O
of	O
the	O
other	O
leukemias	O
were	O
RT-PCR	O
positive	O
.	O

Follow-up	O
of	O
three	O
patient	O
showed	O
residual	O
positivity	O
in	O
apparent	O
complete	O
remission	O
.	O

These	O
data	O
show	O
that	O
CBF	B-RNA
beta-MYH11	I-RNA
fusion	I-RNA
transcripts	I-RNA
occur	O
not	O
only	O
in	O
the	O
vast	O
majority	O
of	O
typical	O
AML	O
M4Eo	O
,	O
but	O
also	O
in	O
approximately	O
10	O
%	O
of	O
AML	O
M4	O
without	O
eosinophilic	O
abnormalities	O
,	O
a	O
much	O
higher	O
incidence	O
than	O
the	O
sporadic	O
reports	O
of	O
chromosome	B-DNA
16	I-DNA
abnormalities	O
in	O
AML	O
M4	O
would	O
suggest	O
.	O

Taken	O
together	O
with	O
the	O
detection	O
of	O
CBF	B-DNA
beta	I-DNA
-	O
MYH11	B-RNA
transcripts	I-RNA
in	O
the	O
absence	O
of	O
apparent	O
chromosome	B-DNA
16	I-DNA
abnormalities	O
by	O
classical	O
banding	O
techniques	O
,	O
these	O
data	O
show	O
that	O
additional	O
screening	O
by	O
either	O
RT-PCR	O
or	O
FISH	O
should	O
be	O
performed	O
in	O
all	O
AML	O
M4	O
,	O
regardless	O
of	O
morphologic	O
features	O
,	O
to	O
allow	O
accurate	O
evaluation	O
of	O
the	O
prognostic	O
importance	O
of	O
this	O
fusion	B-RNA
transcript	I-RNA
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Detection	NULL
of	NULL
the	NULL
Chromosome	NULL
16	NULL
CBFB-MYH11	NULL
Fusion	NULL
Transcript	NULL
in	NULL
Myelomonocytic	NULL
Leukemias	NULL
By	NULL
Héléne	NULL
Poirel	NULL
,	NULL
Isabelle	NULL
Radford-Weiss	NULL
,	NULL
Katrina	NULL
Rack	NULL
,	NULL
Xavier	NULL
Troussard	NULL
,	NULL
Agnés	NULL
Veil	NULL
,	NULL
Frangoise	NULL
Valensi	NULL
,	NULL
Frangoise	NULL
Picard	NULL
,	NULL
Martine	NULL
Guesnu	NULL
,	NULL
Daniel	NULL
Leboeuf	NULL
,	NULL
Josianne	NULL
Melle	NULL
,	NULL
Frangois	NULL
Dreyfus	NULL
,	NULL
Georges	NULL
Flandrin	NULL
,	NULL
and	NULL
Elizabeth	NULL
Macintyre	NULL
Karyotypic	NULL
detection	NULL
of	NULL
chromosomal	NULL
16	NULL
abnormalities	NULL
classically	NULL
associated	NULL
with	NULL
AML	NULL
M4Eo	NULL
can	NULL
be	NULL
difficult	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
two	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
inv	NULL
{	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
,	NULL
CBFB	NULL
and	NULL
MYH11	NULL
,	NULL
has	NULL
allowed	NULL
the	NULL
detection	NULL
of	NULL
fusion	NULL
transcripts	NULL
by	NULL
reverse-transcriptase	NULL
polymerase	NULL
chain	NULL
reaction	NULL
{	NULL
(	NULL
RT-PCR	NULL
)	NULL
.	NULL

We	NULL
have	NULL
analyzed	NULL
CBFB-MYH11	NULL
fusion	NULL
transcripts	NULL
by	NULL
RT-PCR	NULL
in	NULL
myelomonocytic	NULL
leukemias	NULL
,	NULL
with	NULL
or	NULL
without	NULL
eosinophilia	NULL
,	NULL
to	NULL
determine	NULL
whether	NULL
their	NULL
presence	NULL
correlates	NULL
with	NULL
morphology	NULL
.	NULL

Fifty-three	NULL
cases	NULL
(	NULL
11	NULL
AML	NULL
M4EOo	NULL
;	NULL
1	NULL
AML	NULL
M4	NULL
with	NULL
atypical	NULL
abnormal	NULL
eosinophils	NULL
(	NULL
AML	NULL
M4	NULL
``	NULL
Eo	NULL
'	NULL
``	NULL
)	NULL
;	NULL
29	NULL
AML	NULL
M4	NULL
;	NULL
8	NULL
AML	NULL
M5	NULL
;	NULL
3	NULL
CMML	NULL
;	NULL
and	NULL
1	NULL
AML	NULL
M2	NULL
with	NULL
eosino-philia	NULL
)	NULL
were	NULL
analyzed	NULL
.	NULL

All	NULL
11	NULL
typical	NULL
AML	NULL
M4EOo	NULL
were	NULL
MYH11	NULL
positive	NULL
.	NULL

The	NULL
single	NULL
case	NULL
of	NULL
AML	NULL
M4	NULL
with	NULL
distinctive	NULL
eosinophil	NULL
abnormalities	NULL
was	NULL
negative	NULL
by	NULL
karyotype	NULL
,	NULL
RT-PCR	NULL
and	NULL
fluorescent	NULL
in	NULL
situ	NULL
hybridization	NULL
(	NULL
FISH	NULL
)	NULL
.	NULL

Three	NULL
of	NULL
29	NULL
(	NULL
10	NULL
%	NULL
)	NULL
AML	NULL
M4	NULL
without	NULL
abnormal	NULL
eosinophils	NULL
were	NULL
CBFG-MYH11	NULL
positive	NULL
,	NULL
1	NULL
of	NULL
which	NULL
did	NULL
not	NULL
show	NULL
any	NULL
apparent	NULL
chro-	NULL
DISTINCT	NULL
SUBSET	NULL
of	NULL
patients	NULL
with	NULL
acute	NULL
myelomonocytic	NULL
leukemia	NULL
associated	NULL
with	NULL
abnormal	NULL
bone	NULL
marrow	NULL
eosinophilic	NULL
precursors	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
AML	NULL
M4	NULL
with	NULL
eosinophilia	NULL
(	NULL
AML	NULL
M4EOo	NULL
)	NULL
.	NULL
'	NULL

''	NULL
This	NULL
category	NULL
includes	NULL
>	NULL
~6	NULL
%	NULL
of	NULL
patients	NULL
with	NULL
AML	NULL
and	NULL
around	NULL
20	NULL
%	NULL
of	NULL
AML	NULL
M4	NULL
.	NULL
``	NULL

It	NULL
is	NULL
defined	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
morphologic	NULL
,	NULL
cytochem-ical	NULL
,	NULL
and	NULL
ultrastructural	NULL
abnormalities	NULL
in	NULL
the	NULL
eosinophil	NULL
lin-eage	NULL
,	NULL
which	NULL
usually	NULL
amounts	NULL
to	NULL
5	NULL
%	NULL
or	NULL
more	NULL
of	NULL
nonerythroid	NULL
cells	NULL
.	NULL
``	NULL

Identification	NULL
of	NULL
AML	NULL
M4Eo	NULL
is	NULL
important	NULL
because	NULL
it	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
relatively	NULL
favorable	NULL
prognosis	NULL
,	NULL
``	NULL
``	NULL
both	NULL
with	NULL
regard	NULL
to	NULL
the	NULL
complete	NULL
remission	NULL
rate	NULL
and	NULL
the	NULL
duration	NULL
of	NULL
remission	NULL
and	NULL
survival	NULL
when	NULL
compared	NULL
with	NULL
other	NULL
AMLM4	NULL
treated	NULL
similarly	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
AML	NULL
M4Eo	NULL
show	NULL
structural	NULL
abnormalities	NULL
of	NULL
chromosome	NULL
16	NULL
,	NULL
most	NULL
frequently	NULL
involving	NULL
16p13	NULL
and	NULL
16422	NULL
,	NULL
leading	NULL
either	NULL
to	NULL
a	NULL
pericentric	NULL
inversion	NULL
,	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q22	NULL
)	NULL
°	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
or	NULL
,	NULL
less	NULL
commonly	NULL
(	NULL
up	NULL
to	NULL
30	NULL
%	NULL
of	NULL
cases	NULL
)	NULL
,	NULL
to	NULL
a	NULL
translocation	NULL
between	NULL
the	NULL
two	NULL
homologous	NULL
chromosomes	NULL
,	NULL
t	NULL
(	NULL
16	NULL
;	NULL
,16	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q22	NULL
)	NULL
.	NULL
'	NULL

Cytogenetic	NULL
detection	NULL
of	NULL
inversions	NULL
and	NULL
small	NULL
deletions	NULL
of	NULL
chromosome	NULL
16	NULL
by	NULL
standard	NULL
karyotype	NULL
analysis	NULL
can	NULL
be	NULL
difficult	NULL
,	NULL
especially	NULL
following	NULL
R-banding	NULL
techniques	NULL
.	NULL

Although	NULL
the	NULL
majority	NULL
of	NULL
inv	NULL
{	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q22	NULL
)	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
AML	NULL
M4Eo	NULL
,	NULL
this	NULL
abnormality	NULL
has	NULL
occasionally	NULL
been	NULL
described	NULL
in	NULL
other	NULL
myeloid	NULL
malignancies	NULL
,	NULL
including	NULL
AML	NULL
M2	NULL
,	NULL
M4	NULL
without	NULL
eosinophilia	NULL
,	NULL
M5	NULL
,	NULL
the	NULL
myelodysplastic	NULL
syndromes	NULL
(	NULL
MDS	NULL
)	NULL
,	NULL
and	NULL
blast	NULL
crisis	NULL
of	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
.	NULL
``	NULL

The	NULL
majority	NULL
of	NULL
MDS	NULL
cases	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
eosinophilia	NULL
,	NULL
abnormal	NULL
eosinophils	NULL
or	NULL
with	NULL
transformation	NULL
to	NULL
AML	NULL
M4Eo	NULL
.	NULL
``	NULL

Chromosomal	NULL
abnormalities	NULL
involving	NULL
16q22	NULL
and	NULL
several	NULL
other	NULL
chromosomes	NULL
,	NULL
including	NULL
3q24	NULL
,	NULL
5q33	NULL
,	NULL
14g32	NULL
,	NULL
4435	NULL
,	NULL
and	NULL
1p31	NULL
,	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
patients	NULL
with	NULL
myeloid	NULL
malignancies	NULL
(	NULL
AML	NULL
M4	NULL
,	NULL
MDS	NULL
)	NULL
These	NULL
have	NULL
often	NULL
been	NULL
associated	NULL
with	NULL
abnormal	NULL
eosinophils	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
genes	NULL
situated	NULL
at	NULL
16q22	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
abnormal	NULL
eosinophil	NULL
maturation	NULL
.	NULL

Recent	NULL
cloning	NULL
of	NULL
the	NULL
16p	NULL
and	NULL
16q	NULL
breakpoints	NULL
identified	NULL
Blood	NULL
,	NULL
Vol	NULL
85	NULL
,	NULL
No	NULL
5	NULL
(	NULL
March	NULL
1	NULL
}	NULL
,	NULL
1995	NULL
:	NULL
pp	NULL
1313-1322	NULL
mosome	NULL
16	NULL
abnormalities	NULL
by	NULL
classical	NULL
metaphase	NULL
analysis	NULL
(	NULL
2	NULL
not	NULL
tested	NULL
)	NULL
.	NULL

Both	NULL
cases	NULL
tested	NULL
also	NULL
showed	NULL
MYH11	NULL
genomic	NULL
rearrangement	NULL
.	NULL

None	NULL
of	NULL
the	NULL
other	NULL
leukemias	NULL
were	NULL
RT-PCR	NULL
positive	NULL
.	NULL

Follow-up	NULL
of	NULL
three	NULL
patients	NULL
showed	NULL
residual	NULL
positivity	NULL
in	NULL
apparent	NULL
complete	NULL
remission	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
fusion	NULL
transcripts	NULL
occur	NULL
not	NULL
only	NULL
in	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
typical	NULL
AML	NULL
M4Eo	NULL
,	NULL
but	NULL
also	NULL
in	NULL
~10	NULL
%	NULL
of	NULL
AML	NULL
M4	NULL
without	NULL
eosinophilic	NULL
abnormalities	NULL
,	NULL
a	NULL
much	NULL
higher	NULL
incidence	NULL
than	NULL
the	NULL
sporadic	NULL
reports	NULL
of	NULL
chromosome	NULL
16	NULL
abnormalities	NULL
in	NULL
AML	NULL
M4	NULL
would	NULL
suggest	NULL
.	NULL

Taken	NULL
together	NULL
with	NULL
the	NULL
detection	NULL
of	NULL
CBFB-MYH11	NULL
transcripts	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
apparent	NULL
chromosome	NULL
16	NULL
abnormalities	NULL
by	NULL
classical	NULL
banding	NULL
tech-niques	NULL
,	NULL
these	NULL
data	NULL
show	NULL
that	NULL
additional	NULL
screening	NULL
by	NULL
either	NULL
RT-PCR	NULL
or	NULL
FISH	NULL
should	NULL
be	NULL
performed	NULL
in	NULL
all	NULL
AML	NULL
M4	NULL
,	NULL
regardless	NULL
of	NULL
morphologic	NULL
features	NULL
,	NULL
to	NULL
allow	NULL
accurate	NULL
evaluation	NULL
of	NULL
the	NULL
prognostic	NULL
importance	NULL
of	NULL
this	NULL
fusion	NULL
transcript	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

the	NULL
two	NULL
genes	NULL
involved	NULL
:	NULL
CBF	NULL
and	NULL
MYH11	NULL
``	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

MYH11	NULL
,	NULL
situated	NULL
at	NULL
16p13	NULL
,	NULL
codes	NULL
for	NULL
a	NULL
smooth	NULL
muscle	NULL
myosin	NULL
heavy-chain	NULL
gene	NULL
.	NULL

The	NULL
CBF	NULL
}	NULL
gene	NULL
,	NULL
also	NULL
known	NULL
as	NULL
PEBP2/3	NULL
,	NULL
is	NULL
situated	NULL
at	NULL
16q22	NULL
and	NULL
codes	NULL
for	NULL
the	NULL
3	NULL
subunit	NULL
of	NULL
core	NULL
binding	NULL
factor	NULL
(	NULL
CBF	NULL
)	NULL
,	NULL
a	NULL
heterodimeric	NULL
transcription	NULL
factor	NULL
known	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
enhancers	NULL
of	NULL
various	NULL
murine	NULL
leukemia	NULL
viruses	NULL
``	NULL
and	NULL
to	NULL
similar	NULL
motifs	NULL
in	NULL
the	NULL
enhancers	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
genes	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
The	NULL
CBFa	NULL
(	NULL
or	NULL
PEBP2	NULL
@	NULL
)	NULL
subunit	NULL
is	NULL
identical	NULL
to	NULL
AML1	NULL
,	NULL
one	NULL
of	NULL
the	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
translocation	NULL
associated	NULL
with	NULL
AML	NULL
M2	NULL
.	NULL
``	NULL

In	NULL
vitro	NULL
analysis	NULL
indicates	NULL
that	NULL
murine	NULL
CBF	NULL
does	NULL
not	NULL
bind	NULL
directly	NULL
to	NULL
DNA	NULL
,	NULL
but	NULL
forms	NULL
a	NULL
heterodimeric	NULL
complex	NULL
with	NULL
CBFa	NULL
,	NULL
thus	NULL
stabilizing	NULL
its	NULL
interaction	NULL
with	NULL
DNA	NULL
.	NULL
``	NULL

Molecular	NULL
analysis	NULL
of	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
samples	NULL
showed	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
in-frame	NULL
fusion	NULL
messenger	NULL
RNA	NULL
from	NULL
the	NULL
abnormal	NULL
16p	NULL
connecting	NULL
the	NULL
first	NULL
165	NULL
amino	NULL
acids	NULL
of	NULL
CBF	NULL
to	NULL
the	NULL
tail	NULL
region	NULL
of	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
MYH11	NULL
.	NULL

The	NULL
clustering	NULL
of	NULL
breakpoints	NULL
within	NULL
the	NULL
fusion	NULL
transcript	NULL
allowed	NULL
its	NULL
detection	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
Hematology	NULL
,	NULL
Cytogenetics	NULL
,	NULL
and	NULL
CNRA	NULL
URA	NULL
1461	NULL
,	NULL
CHU	NULL
Necker-Enfants	NULL
Malades	NULL
and	NULL
University	NULL
Paris	NULL
V	NULL
,	NULL
Paris	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Hematology	NULL
,	NULL
Hopital	NULL
Clémenceau	NULL
,	NULL
Caen	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Hematology	NULL
,	NULL
Hopital	NULL
Cochin	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
.	NULL

Submitted	NULL
August	NULL
24	NULL
,	NULL
1994	NULL
;	NULL
accepted	NULL
October	NULL
24	NULL
,	NULL
1994	NULL
.	NULL

Supported	NULL
by	NULL
the	NULL
Fondation	NULL
de	NULL
France/Fondation	NULL
Contre	NULL
la	NULL
Leu-cémie	NULL
,	NULL
the	NULL
Fondation	NULL
pour	NULL
la	NULL
Recherche	NULL
Médicale	NULL
,	NULL
the	NULL
Ligue	NULL
Natio-nale	NULL
contre	NULL
le	NULL
Cancer	NULL
(	NULL
Comité	NULL
de	NULL
Paris	NULL
)	NULL
,	NULL
the	NULL
Direction	NULL
de	NULL
Recherche	NULL
Clinique	NULL
de	NULL
L	NULL
'	NULL
Assistance	NULL
Publique-Hopitaux	NULL
de	NULL
Paris	NULL
,	NULL
and	NULL
the	NULL
Leukemia	NULL
Research	NULL
Fund	NULL
of	NULL
Great	NULL
Britain	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Elizabeth	NULL
A.	NULL
Macintyre	NULL
,	NULL
MD	NULL
,	NULL
PhD	NULL
,	NULL
Laboratoire	NULL
d'Hématologie	NULL
,	NULL
Tour	NULL
Pasteur	NULL
,	NULL
Hopital	NULL
Necker-Enfants	NULL
Malades	NULL
,	NULL
149	NULL
,	NULL
rue	NULL
de	NULL
Sevres	NULL
75743	NULL
Paris	NULL
Cédex	NULL
15	NULL
France	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/95/8505-0010	NULL
$	NULL
3.00/0	NULL
1313	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1314	NULL
A	NULL
163	NULL
*	NULL
A	NULL
11	NULL
3.1	NULL
”	NULL
TMYHII	NULL
T	NULL
Baa	NULL
112	NULL
H4	NULL
111	NULL
11.2	NULL
133	NULL
h	NULL
#	NULL
22	NULL
re	NULL
icspa	NULL
Normal	NULL
16	NULL
chromosome	NULL
Inverted	NULL
16	NULL
chromosome	NULL
B	NULL
centromere	NULL
C	NULL
B	NULL
telomere	NULL
994	NULL
1201	NULL
1528	NULL
1921	NULL
MYH11	NULL
C	NULL
1	NULL
M2	NULL
M3	NULL
MI	NULL
Fig	NULL
1.	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
and	NULL
CBFB-MYH11	NULL
:	NULL
(	NULL
A	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
normal	NULL
chromosome	NULL
16	NULL
and	NULL
the	NULL
inv	NULL
{	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
involving	NULL
CBFB	NULL
and	NULL
MYH11	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
direction	NULL
of	NULL
transcription	NULL
.	NULL

The	NULL
localization	NULL
of	NULL
the	NULL
16p	NULL
cosmids	NULL
are	NULL
illustrated	NULL
:	NULL
(	NULL
*	NULL
)	NULL
,	NULL
cosmid	NULL
c40	NULL
;	NULL
(	NULL
#	NULL
)	NULL
,	NULL
cosmid	NULL
c36	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
CBFB-MYH11	NULL
fusion	NULL
transcript	NULL
from	NULL
the	NULL
der	NULL
(	NULL
16p	NULL
)	NULL
chromosome	NULL
:	NULL
the	NULL
location	NULL
of	NULL
the	NULL
4	NULL
MYH11	NULL
breakpoints	NULL
and	NULL
of	NULL
the	NULL
oligonucleotide	NULL
primers	NULL
used	NULL
for	NULL
standard	NULL
and	NULL
nested	NULL
RT-PCR	NULL
analyses	NULL
are	NULL
shown	NULL
.	NULL

by	NULL
reverse	NULL
transcriptase-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
``	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
analyzed	NULL
to	NULL
date	NULL
,	NULL
the	NULL
breakpoint	NULL
in	NULL
the	NULL
fusion	NULL
mRNA	NULL
occurred	NULL
at	NULL
the	NULL
same	NULL
point	NULL
(	NULL
nucleotide	NULL
[	NULL
nt	NULL
]	NULL
495	NULL
)	NULL
in	NULL
the	NULL
CBF/3	NULL
sequence	NULL
,	NULL
leading	NULL
to	NULL
removal	NULL
of	NULL
the	NULL
last	NULL
17	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
potential	NULL
CBF/3	NULL
protein	NULL
.	NULL

Four	NULL
breakpoints	NULL
within	NULL
the	NULL
MYH11	NULL
fusion	NULL
mRNA	NULL
have	NULL
been	NULL
described	NULL
in	NULL
a	NULL
study	NULL
of	NULL
36	NULL
cases	NULL
of	NULL
AML	NULL
M4Eo	NULL
with	NULL
chromosome	NULL
16	NULL
abnormalities	NULL
,	NULL
'	NULL
``	NULL
with	NULL
the	NULL
predominant	NULL
form	NULL
(	NULL
A	NULL
,	NULL
nt	NULL
1921	NULL
)	NULL
occurring	NULL
in	NULL
~80	NULL
%	NULL
(	NULL
29/36	NULL
)	NULL
of	NULL
cases	NULL
and	NULL
the	NULL
variant	NULL
forms	NULL
being	NULL
found	NULL
much	NULL
less	NULL
frequently	NULL
(	NULL
B	NULL
,	NULL
nt	NULL
1528	NULL
,	NULL
1/36	NULL
;	NULL
C	NULL
,	NULL
nt	NULL
1201	NULL
,	NULL
4/36	NULL
;	NULL
D	NULL
,	NULL
nt	NULL
994	NULL
,	NULL
2/36	NULL
)	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
rearrangements	NULL
maintain	NULL
the	NULL
reading	NULL
frame	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
5°	NULL
CBFG-MYH11	NULL
3	NULL
'	NULL
fusion	NULL
transcript	NULL
,	NULL
rather	NULL
than	NULL
the	NULL
potential	NULL
5°	NULL
MYH11-CBF/3	NULL
3	NULL
'	NULL
reciprocal	NULL
transcript	NULL
,	NULL
is	NULL
more	NULL
important	NULL
for	NULL
leukemogenesis	NULL
because	NULL
AML	NULL
M4Eo	NULL
patients	NULL
with	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
and	NULL
an	NULL
associated	NULL
deletion	NULL
centromeric	NULL
to	NULL
the	NULL
p	NULL
arm	NULL
breakpoint	NULL
have	NULL
been	NULL
described	NULL
.	NULL
``	NULL

Furthermore	NULL
,	NULL
Liu	NULL
et	NULL
al	NULL
``	NULL
failed	NULL
to	NULL
detect	NULL
any	NULL
reciprocal	NULL
fusion	NULL
transcripts	NULL
in	NULL
3	NULL
cases	NULL
of	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
view	NULL
of	NULL
the	NULL
recognized	NULL
difficulty	NULL
in	NULL
karyotypic	NULL
detection	NULL
of	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
,	NULL
even	NULL
when	NULL
specifically	NULL
looked	NULL
for	NULL
,	NULL
we	NULL
postulated	NULL
that	NULL
the	NULL
incidence	NULL
of	NULL
fusion	NULL
transcripts	NULL
in	NULL
AML	NULL
M4	NULL
without	NULL
eosinophilia	NULL
may	NULL
be	NULL
higher	NULL
than	NULL
the	NULL
occasional	NULL
reports	NULL
of	NULL
karyotypic	NULL
chromosome	NULL
16	NULL
abnormalities	NULL
would	NULL
suggest	NULL
.	NULL

We	NULL
show	NULL
that	NULL
CBFS-MYH11	NULL
fusion	NULL
transcripts	NULL
occur	NULL
not	NULL
only	NULL
in	NULL
cases	NULL
with	NULL
typical	NULL
M4E0o	NULL
,	NULL
but	NULL
also	NULL
in	NULL
10	NULL
%	NULL
of	NULL
AML	NULL
M4	NULL
without	NULL
abnormal	NULL
eosinophils	NULL
,	NULL
suggesting	NULL
that	NULL
RT-PCR	NULL
screening	NULL
of	NULL
AML	NULL
M4	NULL
leukemias	NULL
will	NULL
improve	NULL
prognostic	NULL
evaluation	NULL
of	NULL
these	NULL
cases	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
CBF3-MYH11	NULL
fusion	NULL
transcripts	NULL
can	NULL
occur	NULL
in	NULL
cases	NULL
with	NULL
POIREL	NULL
ET	NULL
AL	NULL
complex	NULL
chromosome	NULL
16	NULL
abnormalities	NULL
and	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
apparent	NULL
abnormality	NULL
by	NULL
standard	NULL
metaphase	NULL
analysis	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Patients	NULL
.	NULL

Fifty-three	NULL
patients	NULL
(	NULL
50	NULL
AML	NULL
,	NULL
3	NULL
chronic	NULL
myelomonocytic	NULL
leukemia	NULL
[	NULL
CMML	NULL
]	NULL
)	NULL
diagnosed	NULL
and	NULL
treated	NULL
in	NULL
three	NULL
different	NULL
centers	NULL
between	NULL
1986	NULL
and	NULL
1994	NULL
were	NULL
studied	NULL
.	NULL

Median	NULL
age	NULL
was	NULL
46	NULL
years	NULL
(	NULL
range	NULL
,	NULL
2	NULL
months	NULL
to	NULL
78	NULL
years	NULL
)	NULL
,	NULL
with	NULL
23	NULL
males	NULL
and	NULL
30	NULL
females	NULL
.	NULL

RNA	NULL
from	NULL
a	NULL
case	NULL
of	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
positive	NULL
AML	NULL
M4Eo	NULL
showing	NULL
a	NULL
type	NULL
C	NULL
(	NULL
nt	NULL
1201	NULL
)	NULL
breakpoint	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
J.	NULL
Hebert	NULL
&	NULL
F.	NULL
Sigaux	NULL
(	NULL
Hopital	NULL
Saint-Louis	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Morphology	NULL
.	NULL

-	NULL
Morphologic	NULL
diagnosis	NULL
and	NULL
classification	NULL
was	NULL
performed	NULL
on	NULL
bone	NULL
marrow	NULL
and	NULL
peripheral	NULL
blood	NULL
smears	NULL
stained	NULL
by	NULL
May-Griinwald-Giemsa	NULL
,	NULL
according	NULL
to	NULL
the	NULL
French-American-British	NULL
(	NULL
FAB	NULL
)	NULL
cooperative	NULL
criteria	NULL
.	NULL
``	NULL

All	NULL
diagnostic	NULL
marrow	NULL
specimens	NULL
were	NULL
reviewed	NULL
for	NULL
leukemic	NULL
cell	NULL
and	NULL
eosinophil	NULL
morphology	NULL
by	NULL
G.	NULL
Flandrin	NULL
,	NULL
member	NULL
of	NULL
the	NULL
FAB	NULL
cooperative	NULL
group	NULL
.	NULL

Where	NULL
M4	NULL
criteria	NULL
were	NULL
met	NULL
,	NULL
the	NULL
diagnosis	NULL
of	NULL
M4Eo	NULL
was	NULL
restricted	NULL
to	NULL
cases	NULL
with	NULL
characteristic	NULL
eosinophilic	NULL
abnormalities	NULL
in	NULL
bone	NULL
marrow	NULL
cells	NULL
.	NULL

Cytochemical	NULL
analysis	NULL
with	NULL
chloro-acetate	NULL
esterase	NULL
was	NULL
performed	NULL
by	NULL
standard	NULL
techniques	NULL
in	NULL
selected	NULL
AML	NULL
M4	NULL
cases	NULL
.	NULL
``	NULL

Cytogenetic	NULL
analysis	NULL
.	NULL

-	NULL
Chromosome	NULL
analysis	NULL
were	NULL
performed	NULL
on	NULL
bone	NULL
marrow	NULL
cells	NULL
and/or	NULL
unstimulated	NULL
blood	NULL
cells	NULL
(	NULL
24	NULL
and/or	NULL
48	NULL
hours	NULL
in	NULL
vitro	NULL
culture	NULL
)	NULL
with	NULL
GTG	NULL
(	NULL
G-bands	NULL
obtained	NULL
by	NULL
trypsin	NULL
and	NULL
stained	NULL
with	NULL
Giemsa	NULL
)	NULL
and/or	NULL
RHG	NULL
(	NULL
R-bands	NULL
by	NULL
heating	NULL
using	NULL
Giemsa	NULL
)	NULL
techniques	NULL
.	NULL

The	NULL
nomenclature	NULL
used	NULL
to	NULL
describe	NULL
chromosomal	NULL
karyotypic	NULL
abnormalities	NULL
follows	NULL
the	NULL
recommendations	NULL
of	NULL
the	NULL
International	NULL
System	NULL
for	NULL
Human	NULL
Cytogenetic	NULL
Nomenclature	NULL
.	NULL
``	NULL

RT-PCR	NULL
analysis	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
leukemic	NULL
cells	NULL
,	NULL
after	NULL
thawing	NULL
and	NULL
washing	NULL
,	NULL
by	NULL
the	NULL
single-step	NULL
method	NULL
of	NULL
Chomezynski	NULL
and	NULL
Sacchi	NULL
.	NULL
``	NULL

cDNA	NULL
was	NULL
synthesized	NULL
from	NULL
1	NULL
to	NULL
2	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
with	NULL
200	NULL
U	NULL
Moloney-murine	NULL
leukemia	NULL
virus	NULL
(	NULL
M-MLV	NULL
)	NULL
reverse	NULL
transcriptase	NULL
(	NULL
GIBCO-BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
in	NULL
PCR	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
TRIS	NULL
HCI	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
,	NULL
50	NULL
mmol/L	NULL
KCI	NULL
,	NULL
3	NULL
mmol/L	NULL
MgCl	NULL
;	NULL
)	NULL
containing	NULL
random	NULL
hexamer	NULL
primers	NULL
(	NULL
10	NULL
mmol/L	NULL
)	NULL
,	NULL
deoxynucleotide	NULL
triphosphates	NULL
(	NULL
dNTP	NULL
;	NULL
1	NULL
mmol/L	NULL
each	NULL
)	NULL
,	NULL
20	NULL
U	NULL
RNAsin	NULL
,	NULL
10	NULL
%	NULL
dithio-threitol	NULL
(	NULL
DTT	NULL
)	NULL
in	NULL
diethyl	NULL
pyrocarbonate	NULL
treated	NULL
water	NULL
(	NULL
final	NULL
reaction	NULL
volume	NULL
20	NULL
4L	NULL
)	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
hour	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
heated	NULL
to	NULL
70°C	NULL
for	NULL
10	NULL
minutes	NULL
then	NULL
cooled	NULL
on	NULL
ice	NULL
.	NULL

Four	NULL
microliters	NULL
of	NULL
cDNA	NULL
(	NULL
0.2	NULL
to	NULL
0.4	NULL
ug	NULL
RNA	NULL
)	NULL
,	NULL
PCR	NULL
buffer	NULL
as	NULL
above	NULL
,	NULL
50	NULL
mmol/L	NULL
TRIS	NULL
HCI	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
,	NULL
75	NULL
mmol/L	NULL
KCI	NULL
,	NULL
2.5	NULL
mmol/L	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mmol/L	NULL
dNTP	NULL
,	NULL
6	NULL
%	NULL
formamide	NULL
,	NULL
0.4	NULL
umol/L	NULL
oligonucleotide	NULL
primers	NULL
,	NULL
and	NULL
2.5	NULL
U	NULL
Taq	NULL
polymerase	NULL
(	NULL
Perkin-Elmer	NULL
Cetus	NULL
,	NULL
Norwalk	NULL
,	NULL
CT	NULL
)	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
50	NULL
ul	NULL
were	NULL
amplified	NULL
for	NULL
35	NULL
cycles	NULL
in	NULL
a	NULL
DNA	NULL
thermal	NULL
cycler	NULL
(	NULL
Biometra	NULL
,	NULL
Géttingen	NULL
,	NULL
Germany	NULL
)	NULL
with	NULL
a	NULL
stepwise	NULL
program	NULL
consisting	NULL
of	NULL
92°C	NULL
for	NULL
30	NULL
seconds	NULL
,	NULL
57°C	NULL
(	NULL
M1	NULL
and	NULL
M3	NULL
)	NULL
or	NULL
60°C	NULL
(	NULL
M2	NULL
)	NULL
for	NULL
1	NULL
minute	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1	NULL
minute	NULL
.	NULL

This	NULL
was	NULL
preceeded	NULL
by	NULL
a	NULL
denaturation	NULL
step	NULL
of	NULL
92°C	NULL
for	NULL
3	NULL
minutes	NULL
before	NULL
the	NULL
first	NULL
cycle	NULL
.	NULL

The	NULL
final	NULL
extension	NULL
phase	NULL
was	NULL
increased	NULL
to	NULL
10	NULL
minutes	NULL
.	NULL

RT-PCR	NULL
screening	NULL
for	NULL
MYH11	NULL
fusion	NULL
transcripts	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
sense	NULL
CBFS	NULL
primer	NULL
,	NULL
C1	NULL
,	NULL
5-GCAGGCAAGGTATATTTGAAGG-3	NULL
'	NULL
(	NULL
nt	NULL
253-274	NULL
)	NULL
and	NULL
either	NULL
the	NULL
antisense	NULL
primer	NULL
,	NULL
M1	NULL
,	NULL
5-CTCTTCTCCTCATTC-TGCTC-3	NULL
'	NULL
(	NULL
reverse	NULL
sequence	NULL
of	NULL
nt	NULL
2095-2114	NULL
of	NULL
MYH11	NULL
)	NULL
'*	NULL
``	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
or	NULL
,	NULL
in	NULL
an	NULL
independant	NULL
PCR	NULL
reaction	NULL
,	NULL
the	NULL
M3	NULL
antisense	NULL
primer	NULL
,	NULL
5-TGAAGCAACTCCTGGGTGTC-3	NULL
'	NULL
(	NULL
reverse	NULL
sequence	NULL
of	NULL
nt	NULL
1298	NULL
through	NULL
1317	NULL
of	NULL
MYH11	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
certain	NULL
cases	NULL
were	NULL
also	NULL
amplified	NULL
with	NULL
C1	NULL
and	NULL
an	NULL
additional	NULL
MYH11	NULL
antisense	NULL
primer	NULL
,	NULL
M2	NULL
,	NULL
5'-ACTGCAGCTCCTGCACCTGC-3	NULL
'	NULL
(	NULL
reverse	NULL
sequence	NULL
of	NULL
nt	NULL
1119	NULL
through	NULL
1138	NULL
of	NULL
MYH11	NULL
)	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
size-fractionated	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
visualized	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

Quality	NULL
of	NULL
RNA	NULL
was	NULL
assessed	NULL
by	NULL
concurrent	NULL
amplification	NULL
of	NULL
3-actin	NULL
transcripts	NULL
from	NULL
the	NULL
same	NULL
cDNA	NULL
using	NULL
oligonucleotide	NULL
primers	NULL
and	NULL
conditions	NULL
as	NULL
described	NULL
in	NULL
``	NULL
``	NULL
and	NULL
,	NULL
in	NULL
unique	NULL
patient	NULL
number	NULL
(	NULL
UPN	NULL
)	NULL
11	NULL
,	NULL
by	NULL
amplification	NULL
of	NULL
Abelson	NULL
transcripts	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CHROMOSOME	NULL
16	NULL
CBFS-MYH11	NULL
using	NULL
exon	NULL
2	NULL
and	NULL
exon	NULL
3	NULL
primers	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Peripheral	NULL
blood	NULL
leukocyte	NULL
(	NULL
PBL	NULL
)	NULL
RNA	NULL
and	NULL
no-RNA-negative	NULL
controls	NULL
were	NULL
reverse	NULL
transcribed	NULL
and	NULL
amplified	NULL
in	NULL
parallel	NULL
with	NULL
all	NULL
patient	NULL
samples	NULL
.	NULL

Standard	NULL
precautions	NULL
were	NULL
undertaken	NULL
to	NULL
prevent	NULL
product	NULL
carry-over	NULL
.	NULL

For	NULL
the	NULL
detection	NULL
of	NULL
residual	NULL
tumor	NULL
cells	NULL
,	NULL
a	NULL
seminested	NULL
internal	NULL
amplification	NULL
was	NULL
performed	NULL
from	NULL
4	NULL
gL	NULL
of	NULL
a	NULL
1:100	NULL
dilution	NULL
of	NULL
amplified	NULL
product	NULL
for	NULL
35	NULL
cycles	NULL
under	NULL
identical	NULL
conditions	NULL
,	NULL
but	NULL
with	NULL
an	NULL
internal	NULL
CBF	NULL
primer	NULL
C2	NULL
(	NULL
5-GGGCTGTCTGGAGTT-TGATG-3	NULL
'	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
amplified	NULL
products	NULL
and	NULL
to	NULL
aid	NULL
detection	NULL
of	NULL
any	NULL
larger	NULL
fragments	NULL
generated	NULL
with	NULL
the	NULL
C1-M1	NULL
pair	NULL
of	NULL
oligo-nucleotides	NULL
,	NULL
PCR	NULL
products	NULL
were	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
by	NULL
Southern	NULL
blotting	NULL
and	NULL
hybridized	NULL
with	NULL
the	NULL
internal	NULL
CBF	NULL
oligonucleotide	NULL
probe	NULL
C2	NULL
labeled	NULL
with	NULL
gamma	NULL
*P	NULL
adenosine	NULL
triphosphate	NULL
(	NULL
ATP	NULL
)	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

Southern-blot	NULL
analysis	NULL
and	NULL
DNA	NULL
probes	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
RT-PCR	NULL
findings	NULL
in	NULL
selected	NULL
cases	NULL
,	NULL
high	NULL
molecular-weight	NULL
DNA	NULL
was	NULL
extracted	NULL
from	NULL
cryopreserved	NULL
cells	NULL
and	NULL
digested	NULL
with	NULL
EcoRI	NULL
,	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
0.7	NULL
%	NULL
agarose	NULL
,	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
(	NULL
Hybond	NULL
N+	NULL
,	NULL
Amersham	NULL
)	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
random	NULL
primed	NULL
radiolabeled	NULL
MYH11	NULL
probe	NULL
.	NULL

The	NULL
cDNA	NULL
MYH11	NULL
probe	NULL
,	NULL
LISP2	NULL
,	NULL
was	NULL
a	NULL
2-kb	NULL
EcoRI	NULL
insert	NULL
in	NULL
Bluescript	NULL
kindly	NULL
provided	NULL
by	NULL
Hans	NULL
Dauwerse	NULL
.	NULL
``	NULL

''	NULL
Membranes	NULL
were	NULL
washed	NULL
at	NULL
a	NULL
final	NULL
stringency	NULL
of	NULL
0.2	NULL
x	NULL
saline	NULL
sodium	NULL
citrate	NULL
(	NULL
SSC	NULL
)	NULL
and	NULL
0.5	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
at	NULL
65°C	NULL
before	NULL
autoradiography	NULL
.	NULL

Fluorescent	NULL
in	NULL
situ	NULL
hybridization	NULL
(	NULL
FISH	NULL
)	NULL
analysis	NULL
.	NULL

-	NULL
Cosmids	NULL
36	NULL
and	NULL
40	NULL
,	NULL
which	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Hans	NULL
Dauwerse	NULL
``	NULL
``	NULL
and	NULL
are	NULL
located	NULL
centromeric	NULL
and	NULL
telomeric	NULL
,	NULL
respectively	NULL
,	NULL
to	NULL
the	NULL
inversion	NULL
16	NULL
short	NULL
arm	NULL
breakpoint	NULL
,	NULL
were	NULL
used	NULL
for	NULL
FISH	NULL
studies	NULL
.	NULL

Probes	NULL
were	NULL
labeled	NULL
with	NULL
biotin-14-dATP	NULL
(	NULL
Bionick	NULL
kit	NULL
,	NULL
GIBCO-BRL	NULL
)	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
was	NULL
performed	NULL
as	NULL
follows	NULL
:	NULL
50	NULL
ng	NULL
of	NULL
each	NULL
cosmid	NULL
was	NULL
combined	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
human	NULL
Cot-1	NULL
competitor	NULL
DNA	NULL
in	NULL
10	NULL
gL	NULL
of	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
2	NULL
x	NULL
SSC	NULL
,	NULL
10	NULL
%	NULL
dextran	NULL
sulphate	NULL
,	NULL
pH	NULL
7.0	NULL
.	NULL

The	NULL
probe	NULL
mix	NULL
was	NULL
denatured	NULL
at	NULL
75°C	NULL
for	NULL
5	NULL
minutes	NULL
and	NULL
the	NULL
repetitive	NULL
sequences	NULL
were	NULL
allowed	NULL
to	NULL
preanneal	NULL
at	NULL
37°C	NULL
for	NULL
15	NULL
minutes	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
denatured	NULL
at	NULL
70°C	NULL
in	NULL
70	NULL
%	NULL
formamide	NULL
,	NULL
2	NULL
X	NULL
SSC	NULL
PH	NULL
7.0	NULL
for	NULL
4	NULL
minutes	NULL
and	NULL
then	NULL
dehydrated	NULL
through	NULL
a	NULL
cold	NULL
ethanol	NULL
series	NULL
of	NULL
washes	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
hybridized	NULL
overnight	NULL
under	NULL
a	NULL
sealed	NULL
coverslip	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
then	NULL
washed	NULL
3	NULL
times	NULL
at	NULL
37°C	NULL
for	NULL
5	NULL
minutes	NULL
each	NULL
time	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
2	NULL
x	NULL
SSC	NULL
,	NULL
pH	NULL
7.0	NULL
followed	NULL
by	NULL
three	NULL
5-minutes	NULL
washes	NULL
in	NULL
2	NULL
X	NULL
SSC	NULL
,	NULL
pH	NULL
7.0	NULL
.	NULL

The	NULL
biotin-labeled	NULL
sequences	NULL
were	NULL
detected	NULL
with	NULL
goat	NULL
antibiotin	NULL
(	NULL
1/50	NULL
dilution	NULL
,	NULL
Sigma	NULL
Chemical	NULL
Co	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
followed	NULL
by	NULL
rabbit-antigoat	NULL
conjuguated	NULL
to	NULL
FITC	NULL
(	NULL
1/80	NULL
dilution	NULL
,	NULL
Sigma	NULL
)	NULL
.	NULL

The	NULL
chromosomes	NULL
were	NULL
counter-stained	NULL
with	NULL
propidium	NULL
iodide	NULL
and	NULL
the	NULL
slides	NULL
were	NULL
analyzed	NULL
using	NULL
a	NULL
Leitz	NULL
Axio-phot	NULL
microscope	NULL
and	NULL
photographed	NULL
using	NULL
Ektachrome	NULL
ASA	NULL
400	NULL
film	NULL
.	NULL

RESULTS	NULL
Patient	NULL
characteristics	NULL
.	NULL

|	NULL
The	NULL
53	NULL
cases	NULL
studied	NULL
were	NULL
classified	NULL
without	NULL
prior	NULL
knowledge	NULL
of	NULL
RT-PCR	NULL
findings	NULL
as	NULL
follows	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
:	NULL
11	NULL
AML	NULL
M4Eo	NULL
with	NULL
typical	NULL
bone	NULL
marrow	NULL
eosinophilic	NULL
abnormalities	NULL
(	NULL
median	NULL
10	NULL
%	NULL
eosinophil	NULL
precur-sors	NULL
,	NULL
range	NULL
,	NULL
3	NULL
%	NULL
to	NULL
50	NULL
%	NULL
)	NULL
including	NULL
classical	NULL
morphologic	NULL
eosinophil	NULL
abnormalities	NULL
such	NULL
as	NULL
the	NULL
presence	NULL
of	NULL
cells	NULL
containing	NULL
large	NULL
,	NULL
irregular	NULL
,	NULL
immature	NULL
,	NULL
dark	NULL
purple	NULL
rather	NULL
than	NULL
bluish	NULL
granules	NULL
,	NULL
admixed	NULL
with	NULL
normal	NULL
appearing	NULL
granules	NULL
(	NULL
Fig	NULL
2a	NULL
)	NULL
;	NULL
1	NULL
AML	NULL
M4	NULL
with	NULL
bone	NULL
marrow	NULL
eosinophilia	NULL
(	NULL
14	NULL
%	NULL
)	NULL
,	NULL
named	NULL
AML	NULL
M4*Eo	NULL
``	NULL
,	NULL
but	NULL
with	NULL
distinct	NULL
bone	NULL
marrow	NULL
abnormalities	NULL
of	NULL
eosinophilic	NULL
precursors	NULL
such	NULL
as	NULL
small	NULL
cells	NULL
arrested	NULL
at	NULL
the	NULL
promyelocyte	NULL
or	NULL
myelocyte	NULL
stage	NULL
with	NULL
eccentric	NULL
nuclei	NULL
,	NULL
normal	NULL
cytoplasmic	NULL
eosinophilic	NULL
granules	NULL
clustered	NULL
around	NULL
a	NULL
large	NULL
Golgi	NULL
zone	NULL
,	NULL
and	NULL
a	NULL
basophilic	NULL
vacuolated	NULL
cytoplasm	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
;	NULL
29	NULL
AML	NULL
M4	NULL
without	NULL
any	NULL
bone	NULL
marrow	NULL
1315	NULL
eosinophilic	NULL
abnormalities	NULL
(	NULL
and	NULL
with	NULL
=5	NULL
%	NULL
eosinophils	NULL
)	NULL
;	NULL
8	NULL
AML	NULL
MS	NULL
and	NULL
3	NULL
CMML	NULL
without	NULL
any	NULL
bone	NULL
marrow	NULL
eosinophilic	NULL
abnormalities	NULL
;	NULL
1	NULL
AML	NULL
M2	NULL
with	NULL
normal	NULL
eosinophilia	NULL
(	NULL
~14	NULL
%	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
)	NULL
.	NULL

Karyotypic	NULL
abnormalities	NULL
.	NULL

-	NULL
Karyotype	NULL
analysis	NULL
was	NULL
performed	NULL
in	NULL
42	NULL
cases	NULL
,	NULL
with	NULL
sufficient	NULL
metaphases	NULL
(	NULL
at	NULL
least	NULL
10	NULL
)	NULL
being	NULL
available	NULL
for	NULL
analysis	NULL
in	NULL
41	NULL
cases	NULL
.	NULL

Chromosome	NULL
16	NULL
abnormalities	NULL
(	NULL
including	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
and	NULL
one	NULL
complex	NULL
abnormality	NULL
involving	NULL
one	NULL
chromosome	NULL
16	NULL
)	NULL
were	NULL
observed	NULL
in	NULL
8	NULL
cases	NULL
,	NULL
all	NULL
of	NULL
which	NULL
were	NULL
classified	NULL
as	NULL
M4Eo	NULL
.	NULL

In	NULL
2	NULL
cases	NULL
(	NULL
UPN	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
the	NULL
abnormal	NULL
chromosome	NULL
16	NULL
was	NULL
associated	NULL
with	NULL
trisomy	NULL
22	NULL
.	NULL

Other	NULL
karyotypic	NULL
abnormalities	NULL
and	NULL
the	NULL
number	NULL
of	NULL
metaphases	NULL
analyzed	NULL
are	NULL
listed	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

In	NULL
the	NULL
one	NULL
case	NULL
of	NULL
AML	NULL
showing	NULL
a	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q22	NULL
;	NULL
q22	NULL
)	NULL
,	NULL
UPN	NULL
22	NULL
,	NULL
the	NULL
classification	NULL
as	NULL
AML	NULL
M4	NULL
at	NULL
both	NULL
initial	NULL
presentation	NULL
and	NULL
relapse	NULL
was	NULL
confirmed	NULL
at	NULL
panel	NULL
review	NULL
.	NULL

Ninety	NULL
percent	NULL
of	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
occur	NULL
in	NULL
AML	NULL
M2	NULL
,	NULL
but	NULL
the	NULL
remainder	NULL
classify	NULL
as	NULL
M4	NULL
.	NULL
``	NULL

RT-PCR	NULL
analysis	NULL
of	NULL
this	NULL
case	NULL
showed	NULL
a	NULL
classical	NULL
AMLI-ETO	NULL
fusion	NULL
transcript	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Detection	NULL
of	NULL
CBFB-MYH11	NULL
fusion	NULL
transcripts	NULL
by	NULL
RT-PCR	NULL
.	NULL

Fourteen	NULL
of	NULL
53	NULL
cases	NULL
showed	NULL
a	NULL
CBF	NULL
#	NULL
-MYH11	NULL
fusion	NULL
transcript	NULL
.	NULL

Two	NULL
independent	NULL
amplification	NULL
reactions	NULL
using	NULL
different	NULL
MYH11	NULL
antisense	NULL
primers	NULL
(	NULL
M1	NULL
and	NULL
M3	NULL
)	NULL
were	NULL
performed	NULL
in	NULL
all	NULL
cases	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
parallel	NULL
amplification	NULL
of	NULL
B-actin	NULL
transcripts	NULL
to	NULL
assess	NULL
RNA	NULL
quality	NULL
.	NULL

Primer	NULL
M1	NULL
allows	NULL
detection	NULL
of	NULL
fusion	NULL
transcripts	NULL
containing	NULL
MYH11	NULL
nt	NULL
1921	NULL
(	NULL
A	NULL
)	NULL
and	NULL
nt	NULL
1528	NULL
(	NULL
B	NULL
)	NULL
breakpoints	NULL
,	NULL
whereas	NULL
primer	NULL
M3	NULL
will	NULL
detect	NULL
both	NULL
nt	NULL
1201	NULL
(	NULL
C	NULL
)	NULL
and	NULL
nt	NULL
994	NULL
(	NULL
D	NULL
)	NULL
breakpoints	NULL
.	NULL

Additional	NULL
amplification	NULL
of	NULL
16	NULL
cases	NULL
(	NULL
UPN	NULL
1	NULL
,	NULL
2	NULL
,	NULL
8	NULL
through	NULL
12	NULL
,	NULL
15	NULL
,	NULL
16	NULL
,	NULL
40	NULL
,	NULL
and	NULL
43	NULL
through	NULL
48	NULL
)	NULL
with	NULL
the	NULL
M2	NULL
antisense	NULL
primer	NULL
allowing	NULL
detection	NULL
of	NULL
type	NULL
D	NULL
transcripts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
did	NULL
not	NULL
show	NULL
any	NULL
positive	NULL
cases	NULL
.	NULL

Because	NULL
these	NULL
transcripts	NULL
could	NULL
also	NULL
be	NULL
detected	NULL
with	NULL
the	NULL
M3	NULL
oligonucleotide	NULL
,	NULL
screening	NULL
of	NULL
cases	NULL
was	NULL
undertaken	NULL
with	NULL
the	NULL
latter	NULL
primer	NULL
.	NULL

All	NULL
fusion	NULL
transcripts	NULL
detected	NULL
corresponded	NULL
to	NULL
the	NULL
predominant	NULL
nt	NULL
1921	NULL
(	NULL
A	NULL
)	NULL
breakpoint	NULL
within	NULL
MYH11	NULL
.	NULL

B-actin	NULL
transcripts	NULL
were	NULL
observed	NULL
in	NULL
all	NULL
CBFG3-MYH11-negative	NULL
cases	NULL
(	NULL
Fig	NULL
3A	NULL
)	NULL
.	NULL

Amplification	NULL
of	NULL
a	NULL
positive	NULL
control	NULL
RNA	NULL
from	NULL
a	NULL
case	NULL
of	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
-AML	NULL
with	NULL
a	NULL
type	NULL
C	NULL
breakpoint	NULL
showed	NULL
the	NULL
expected	NULL
337-bp	NULL
band	NULL
with	NULL
primer	NULL
M3	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
,	NULL
showing	NULL
that	NULL
this	NULL
oligonucleotide	NULL
was	NULL
capable	NULL
of	NULL
detecting	NULL
a	NULL
fusion	NULL
transcript	NULL
under	NULL
the	NULL
condition	NULL
used	NULL
.	NULL

Typical	NULL
AML	NULL
M4Eo	NULL
.	NULL

All	NULL
11	NULL
AML	NULL
M4Eo	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
showed	NULL
a	NULL
CBFS-MYH11	NULL
fusion	NULL
transcript	NULL
by	NULL
RT-PCR	NULL
;	NULL
in	NULL
9	NULL
of	NULL
10	NULL
,	NULL
the	NULL
chromosome	NULL
16	NULL
was	NULL
abnormal	NULL
by	NULL
karyotype	NULL
analysis	NULL
.	NULL

The	NULL
fusion	NULL
transcript	NULL
observed	NULL
in	NULL
case	NULL
UPN	NULL
10	NULL
,	NULL
not	NULL
characterized	NULL
by	NULL
classical	NULL
morphologic	NULL
abnormalities	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
but	NULL
by	NULL
an	NULL
unusual	NULL
chromosome	NULL
16	NULL
abnormality	NULL
,	NULL
was	NULL
identical	NULL
with	NULL
regard	NULL
to	NULL
both	NULL
size	NULL
and	NULL
ability	NULL
to	NULL
hybridize	NULL
to	NULL
an	NULL
internal	NULL
probe	NULL
to	NULL
the	NULL
classical	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
cases	NULL
(	NULL
Fig	NULL
3A	NULL
)	NULL
.	NULL

One	NULL
case	NULL
(	NULL
UPN	NULL
3	NULL
)	NULL
of	NULL
typical	NULL
AML	NULL
M4Eo	NULL
showed	NULL
a	NULL
MYH11	NULL
fusion	NULL
transcript	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
four	NULL
analyzable	NULL
metaphases	NULL
were	NULL
normal	NULL
.	NULL

Although	NULL
the	NULL
number	NULL
of	NULL
available	NULL
mitosis	NULL
does	NULL
limit	NULL
the	NULL
validity	NULL
of	NULL
the	NULL
negative	NULL
karyotypic	NULL
result	NULL
,	NULL
it	NULL
does	NULL
support	NULL
the	NULL
recognized	NULL
difficulty	NULL
in	NULL
detecting	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
all	NULL
cases	NULL
with	NULL
a	NULL
karyotypically	NULL
identified	NULL
chromosome	NULL
16	NULL
rearrangement	NULL
and/or	NULL
typical	NULL
eosinophilic	NULL
abnormalities	NULL
have	NULL
an	NULL
abnormal	NULL
CBFS-MYH11	NULL
fusion	NULL
transcript	NULL
,	NULL
as	NULL
recently	NULL
shown	NULL
.	NULL
``	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1316	NULL
POIREL	NULL
ET	NULL
AL	NULL
Table	NULL
1	NULL
.	NULL

Clinical	NULL
,	NULL
Morphologic	NULL
,	NULL
Cytogenetic	NULL
,	NULL
and	NULL
RT-PCR	NULL
Data	NULL
on	NULL
53	NULL
Myelomonocytic	NULL
Leukemias	NULL
UPN	NULL
Age/Sex	NULL
%	NULL
AEos	NULL
Karyotype®	NULL
RT-PCRt	NULL
FU	NULL
11	NULL
AML	NULL
M4Eo	NULL
1	NULL
28/F	NULL
36	NULL
46	NULL
,	NULL
XX	NULL
,	NULL
inv	NULL
{	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
(	NULL
20	NULL
]	NULL
A	NULL
8+	NULL
2	NULL
45/M	NULL
7	NULL
46	NULL
,	NULL
XY	NULL
,	NULL
inv	NULL
{	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
{	NULL
16	NULL
}	NULL
/46	NULL
,	NULL
XY	NULL
,	NULL
inv	NULL
{	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
,	NULL
inv	NULL
{	NULL
5	NULL
)	NULL
{	NULL
p33q35	NULL
)	NULL
[	NULL
2	NULL
]	NULL
A	NULL
7+	NULL
3	NULL
36/F	NULL
12	NULL
46	NULL
,	NULL
XX	NULL
[	NULL
4	NULL
]	NULL
A	NULL
64+	NULL
4	NULL
36/M	NULL
7	NULL
ND	NULL
A	NULL
19+	NULL
5	NULL
44/M	NULL
6	NULL
46	NULL
,	NULL
XY	NULL
,	NULL
inv	NULL
{	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
(	NULL
9	NULL
}	NULL
/46	NULL
,	NULL
XY.inv	NULL
(	NULL
16	NULL
)	NULL
{	NULL
p	NULL
13922	NULL
)	NULL
,	NULL
+	NULL
221201	NULL
A	NULL
25+	NULL
6	NULL
24/M	NULL
3	NULL
46	NULL
,	NULL
XY	NULL
,	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
{	NULL
13	NULL
]	NULL
/47	NULL
,	NULL
XY	NULL
,	NULL
inv	NULL
{	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
,	NULL
+	NULL
22	NULL
(	NULL
5	NULL
]	NULL
A	NULL
7+	NULL
7	NULL
46/F	NULL
10	NULL
46	NULL
,	NULL
X0Ginv	NULL
{	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
[	NULL
151/46.XX	NULL
[	NULL
11	NULL
]	NULL
A	NULL
<	NULL
1-8	NULL
21/M	NULL
19	NULL
46	NULL
,	NULL
XY	NULL
,	NULL
inv	NULL
{	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
[	NULL
18	NULL
]	NULL
A	NULL
8+	NULL
9+	NULL
26/M	NULL
50	NULL
46	NULL
,	NULL
XY	NULL
,	NULL
inv	NULL
{	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
(	NULL
26	NULL
}	NULL
A	NULL
26R-10	NULL
23/M	NULL
22	NULL
48	NULL
,	NULL
XY	NULL
,	NULL
der	NULL
(	NULL
16	NULL
)	NULL
[	NULL
16	NULL
]	NULL
/46	NULL
,	NULL
XY	NULL
[	NULL
2	NULL
]	NULL
A	NULL
7+	NULL
52	NULL
62/F	NULL
5	NULL
46	NULL
,	NULL
XY	NULL
,	NULL
inv	NULL
{	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
{	NULL
29	NULL
]	NULL
A	NULL
3+	NULL
1	NULL
AML	NULL
M4	NULL
``	NULL
Eo	NULL
``	NULL
11	NULL
35/F	NULL
14	NULL
46	NULL
,	NULL
XX	NULL
[	NULL
13	NULL
]	NULL
-	NULL
4+	NULL
29	NULL
AML	NULL
M4	NULL
with	NULL
=5	NULL
%	NULL
eosinophils	NULL
12	NULL
52/M	NULL
0	NULL
47	NULL
,	NULL
XY	NULL
,	NULL
+22134	NULL
}	NULL
/46	NULL
,	NULL
XY	NULL
[	NULL
1	NULL
]	NULL
A	NULL
7+	NULL
13	NULL
67/F	NULL
0	NULL
ND	NULL
A	NULL
<	NULL
1-14	NULL
63/F	NULL
0	NULL
ND	NULL
A	NULL
61R-15	NULL
76/F	NULL
0	NULL
ND	NULL
-	NULL
?	NULL

16	NULL
66/F	NULL
0	NULL
44	NULL
,	NULL
XX	NULL
,	NULL
der	NULL
(	NULL
3	NULL
)	NULL
,	NULL
-5	NULL
,	NULL
-7	NULL
,	NULL
-12+mar	NULL
{	NULL
71/46	NULL
,	NULL
XX	NULL
{	NULL
(	NULL
6	NULL
]	NULL
-	NULL
1-17	NULL
72/F	NULL
0	NULL
46	NULL
,	NULL
XX	NULL
,	NULL
der	NULL
(	NULL
16	NULL
}	NULL
t	NULL
(	NULL
1	NULL
;	NULL
16	NULL
)	NULL
(	NULL
q12	NULL
;	NULL
q11	NULL
)	NULL
1231/46	NULL
,	NULL
XX	NULL
,	NULL
der	NULL
(	NULL
16	NULL
)	NULL
t	NULL
(	NULL
1	NULL
;	NULL
16	NULL
)	NULL
(	NULL
q12	NULL
;	NULL
q11	NULL
)	NULL
,	NULL
+2112	NULL
]	NULL
-	NULL
1+	NULL
18	NULL
52/M	NULL
0	NULL
46	NULL
,	NULL
XY	NULL
-	NULL
41+	NULL
198	NULL
40/M	NULL
0	NULL
46	NULL
,	NULL
XY	NULL
-	NULL
16R-20	NULL
62/M	NULL
0	NULL
46	NULL
,	NULL
XY	NULL
-	NULL
8+	NULL
21	NULL
23/F	NULL
0	NULL
46	NULL
,	NULL
XX	NULL
-	NULL
3R-228	NULL
40/M	NULL
1	NULL
46	NULL
,	NULL
XY	NULL
,	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q22	NULL
;	NULL
922	NULL
)	NULL
-	NULL
16R+	NULL
23	NULL
21/M	NULL
0	NULL
46	NULL
,	NULL
XY.1	NULL
(	NULL
6	NULL
;	NULL
9	NULL
}	NULL
(	NULL
p23	NULL
;	NULL
q34	NULL
)	NULL
[	NULL
15	NULL
]	NULL
/46	NULL
,	NULL
XYI8	NULL
]	NULL
-	NULL
9+	NULL
24	NULL
48/F	NULL
0	NULL
46	NULL
,	NULL
XX	NULL
-	NULL
5SR-25	NULL
64/F	NULL
2	NULL
46	NULL
,	NULL
XX	NULL
-	NULL
7-26+	NULL
51/F	NULL
1	NULL
46	NULL
,	NULL
XX	NULL
,	NULL
t	NULL
(	NULL
1	NULL
;	NULL
3	NULL
)	NULL
(	NULL
p36	NULL
;	NULL
:	NULL
q21	NULL
)	NULL
-	NULL
40R-27	NULL
43/F	NULL
3	NULL
ND	NULL
-	NULL
<	NULL
1-28	NULL
47/€	NULL
0	NULL
46	NULL
,	NULL
XX	NULL
-	NULL
22+	NULL
29	NULL
THF	NULL
0	NULL
45	NULL
,	NULL
XX	NULL
,	NULL
-20	NULL
(	NULL
17	NULL
}	NULL
/46	NULL
,	NULL
XXI3	NULL
]	NULL
-	NULL
1-30	NULL
47/M	NULL
0	NULL
46	NULL
,	NULL
XY	NULL
-	NULL
10+	NULL
31	NULL
70/F	NULL
4	NULL
47	NULL
,	NULL
XX	NULL
,	NULL
+Bet48	NULL
,	NULL
XXX	NULL
,	NULL
+8	NULL
[	NULL
161/46	NULL
,	NULL
XX	NULL
[	NULL
4	NULL
]	NULL
=~	NULL
1-32	NULL
56/F	NULL
0	NULL
46	NULL
,	NULL
XX	NULL
-	NULL
16+	NULL
33	NULL
66/F	NULL
5	NULL
46	NULL
,	NULL
XX	NULL
,	NULL
+der	NULL
(	NULL
3	NULL
)	NULL
,	NULL
-20	NULL
[	NULL
21/46	NULL
,	NULL
XX	NULL
{	NULL
16	NULL
]	NULL
-	NULL
1+	NULL
34	NULL
46/F	NULL
1	NULL
ND	NULL
-	NULL
128-35	NULL
6O/F	NULL
2	NULL
46	NULL
,	NULL
XX	NULL
[	NULL
26	NULL
]	NULL
-	NULL
30R+	NULL
36	NULL
64/F	NULL
1	NULL
46	NULL
,	NULL
XX	NULL
-	NULL
24R+	NULL
37	NULL
40/F	NULL
2	NULL
ND	NULL
-	NULL
53R+	NULL
38	NULL
46/F	NULL
1	NULL
46	NULL
,	NULL
XX	NULL
-	NULL
14+	NULL
39	NULL
67/M	NULL
0	NULL
46	NULL
,	NULL
XY	NULL
-	NULL
<	NULL
1-53	NULL
39/F	NULL
0	NULL
46	NULL
,	NULL
XX	NULL
[	NULL
17	NULL
]	NULL
3+	NULL
8	NULL
AML	NULL
MS	NULL
408	NULL
63/M	NULL
0	NULL
46	NULL
,	NULL
XY	NULL
-	NULL
9R-41	NULL
18/M	NULL
0	NULL
46	NULL
,	NULL
XY	NULL
-	NULL
<	NULL
5+	NULL
42	NULL
59/F	NULL
0	NULL
46	NULL
,	NULL
XX	NULL
-	NULL
128-43	NULL
69/M	NULL
0	NULL
ND	NULL
-	NULL
R-44	NULL
14m/F	NULL
0	NULL
46	NULL
,	NULL
XX	NULL
,	NULL
t	NULL
(	NULL
11	NULL
;	NULL
19	NULL
)	NULL
(	NULL
923	NULL
;	NULL
p13	NULL
)	NULL
-	NULL
14+	NULL
45	NULL
31/M	NULL
1	NULL
16	NULL
,	NULL
XY	NULL
-	NULL
20+	NULL
46	NULL
78/M	NULL
0	NULL
47	NULL
,	NULL
XY	NULL
,	NULL
+8/47	NULL
,	NULL
XY	NULL
,	NULL
+8	NULL
,	NULL
del	NULL
(	NULL
11p	NULL
)	NULL
-	NULL
1-47	NULL
33/M	NULL
0	NULL
46	NULL
,	NULL
XY	NULL
int	NULL
BR-3	NULL
CMML	NULL
48	NULL
32/F	NULL
0	NULL
ND	NULL
-	NULL
6+	NULL
49	NULL
34/F	NULL
3	NULL
ND	NULL
-	NULL
20R-50	NULL
57/M	NULL
3	NULL
46	NULL
,	NULL
XY	NULL
,	NULL
inv	NULL
{	NULL
12	NULL
)	NULL
(	NULL
q14924	NULL
)	NULL
/49	NULL
,	NULL
XY	NULL
,	NULL
inv	NULL
{	NULL
12	NULL
)	NULL
,	NULL
+inv	NULL
(	NULL
12	NULL
)	NULL
}	NULL
,	NULL
+12	NULL
,	NULL
+21	NULL
-	NULL
41	NULL
AML	NULL
M2	NULL
with	NULL
normal	NULL
eosinophilia	NULL
51	NULL
15/M	NULL
14	NULL
ND	NULL
-	NULL
41+	NULL
Abbreviations	NULL
:	NULL
UPN	NULL
,	NULL
unique	NULL
patient	NULL
number	NULL
;	NULL
FU	NULL
,	NULL
follow-up	NULL
in	NULL
months	NULL
;	NULL
+	NULL
,	NULL
alive	NULL
;	NULL
-	NULL
,	NULL
deceased	NULL
,	NULL
;	NULL
R	NULL
,	NULL
relapse	NULL
;	NULL
ND	NULL
,	NULL
not	NULL
done	NULL
.	NULL

®	NULL
Number	NULL
of	NULL
mitoses	NULL
analyzed	NULL
.	NULL

t	NULL
CBFS-MYH11	NULL
fusion	NULL
transcripts	NULL
were	NULL
detected	NULL
using	NULL
C1	NULL
and	NULL
M1	NULL
or	NULL
M3	NULL
MYH11	NULL
primers	NULL
.	NULL

Type	NULL
A	NULL
refers	NULL
to	NULL
the	NULL
MYH11	NULL
nt	NULL
1921	NULL
breakpoint	NULL
.	NULL

£	NULL
Analyzed	NULL
at	NULL
relapse	NULL
.	NULL

§	NULL
Analyzed	NULL
at	NULL
diagnosis	NULL
and	NULL
relapse	NULL
.	NULL

AML	NULL
M4	NULL
with	NULL
distinct	NULL
morphologic	NULL
eosinophil	NULL
abnormalities	NULL
.	NULL

-	NULL
The	NULL
single	NULL
case	NULL
of	NULL
AML	NULL
M4	NULL
showing	NULL
unique	NULL
and	NULL
very	NULL
unusual	NULL
eosinophilic	NULL
abnormalities	NULL
(	NULL
UPN	NULL
11	NULL
)	NULL
was	NULL
negative	NULL
by	NULL
both	NULL
standard	NULL
karyotype	NULL
analysis	NULL
and	NULL
RT-PCR	NULL
,	NULL
including	NULL
after	NULL
hybridization	NULL
of	NULL
both	NULL
C1-M1	NULL
and	NULL
C1-M3	NULL
PCR	NULL
products	NULL
with	NULL
an	NULL
internal	NULL
C2	NULL
radiolabeled	NULL
probe	NULL
(	NULL
Fig	NULL
2B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

At	NULL
original	NULL
morphologic	NULL
classification	NULL
by	NULL
one	NULL
FAB	NULL
cooperative	NULL
group	NULL
member	NULL
(	NULL
G.	NULL
Flandrin	NULL
)	NULL
,	NULL
before	NULL
knowledge	NULL
of	NULL
the	NULL
karyotypic	NULL
or	NULL
molecular	NULL
findings	NULL
,	NULL
the	NULL
distinctive	NULL
features	NULL
precluded	NULL
inclusion	NULL
as	NULL
AML	NULL
M4Eo	NULL
.	NULL

The	NULL
cytochemical	NULL
findings	NULL
were	NULL
also	NULL
unusual	NULL
in	NULL
so	NULL
far	NULL
as	NULL
the	NULL
chloro-acetate	NULL
esterase	NULL
reaction	NULL
was	NULL
negative	NULL
in	NULL
the	NULL
eosinophils	NULL
of	NULL
this	NULL
pa	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Fig	NULL
2	NULL
.	NULL

Morphology	NULL
and	NULL
FISH	NULL
analysis	NULL
in	NULL
AML	NULL
M4Eo	NULL
:	NULL
(	NULL
A	NULL
)	NULL
UPN	NULL
10	NULL
,	NULL
typical	NULL
AML	NULL
M4E0	NULL
.	NULL

(	NULL
Left	NULL
)	NULL
Two	NULL
typical	NULL
abnormal	NULL
eosinophils	NULL
;	NULL
(	NULL
right	NULL
)	NULL
four	NULL
blasts	NULL
,	NULL
one	NULL
typical	NULL
abnormal	NULL
eosinophilic	NULL
precur-sor	NULL
,	NULL
and	NULL
one	NULL
normal	NULL
mature	NULL
eo-sinophil	NULL
.	NULL

(	NULL
B	NULL
)	NULL
UPN	NULL
11	NULL
,	NULL
atypical	NULL
AML	NULL
M4EOo	NULL
(	NULL
see	NULL
text	NULL
for	NULL
further	NULL
description	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
FISH	NULL
hybridization	NULL
with	NULL
cosmids	NULL
c40	NULL
and	NULL
c36	NULL
in	NULL
UPN	NULL
52	NULL
with	NULL
inv	NULL
{	NULL
16	NULL
)	NULL
:	NULL
the	NULL
white	NULL
arrow	NULL
points	NULL
out	NULL
the	NULL
inverted	NULL
chromosome	NULL
16	NULL
(	NULL
cosmids	NULL
binding	NULL
to	NULL
both	NULL
the	NULL
long	NULL
and	NULL
the	NULL
short	NULL
arm	NULL
)	NULL
,	NULL
the	NULL
normal	NULL
chromosome	NULL
16	NULL
is	NULL
shown	NULL
by	NULL
the	NULL
white	NULL
dot	NULL
(	NULL
signals	NULL
only	NULL
on	NULL
the	NULL
short	NULL
arm	NULL
)	NULL
.	NULL

tient	NULL
,	NULL
unlike	NULL
classical	NULL
cases	NULL
of	NULL
AML	NULL
M4Eo	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL
``	NULL

Recent	NULL
reports	NULL
have	NULL
shown	NULL
that	NULL
DNA	NULL
contamination	NULL
of	NULL
RNA	NULL
samples	NULL
extracted	NULL
by	NULL
the	NULL
phenol	NULL
chloroform	NULL
technique	NULL
,	NULL
as	NULL
performed	NULL
here	NULL
,	NULL
can	NULL
lead	NULL
to	NULL
amplification	NULL
of	NULL
apparent	NULL
-actin	NULL
transcripts	NULL
from	NULL
pseudogenes	NULL
,	NULL
thus	NULL
providing	NULL
an	NULL
inaccurate	NULL
assessment	NULL
of	NULL
the	NULL
quality	NULL
of	NULL
the	NULL
RNA	NULL
.	NULL
``	NULL

To	NULL
exclude	NULL
this	NULL
possible	NULL
explanation	NULL
for	NULL
the	NULL
absence	NULL
of	NULL
CBFS-MYH11	NULL
transcripts	NULL
in	NULL
this	NULL
case	NULL
,	NULL
we	NULL
confirmed	NULL
the	NULL
presence	NULL
of	NULL
amplifiable	NULL
RNA	NULL
by	NULL
showing	NULL
appropriately	NULL
sized	NULL
bands	NULL
after	NULL
RT-PCR	NULL
amplification	NULL
of	NULL
Abelson	NULL
transcripts	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
*	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
was	NULL
unlikely	NULL
that	NULL
the	NULL
negative	NULL
result	NULL
was	NULL
caused	NULL
by	NULL
RNA	NULL
degradation	NULL
.	NULL

AML	NULL
M4	NULL
without	NULL
apparent	NULL
eosinophil	NULL
abnormalities	NULL
.	NULL

Three	NULL
of	NULL
29	NULL
(	NULL
10	NULL
%	NULL
)	NULL
AML	NULL
M4	NULL
without	NULL
eosinophilia	NULL
showed	NULL
a	NULL
CBFG-MYH11	NULL
fusion	NULL
transcript	NULL
on	NULL
two	NULL
different	NULL
cDNA	NULL
samples	NULL
.	NULL

Chromosome	NULL
16	NULL
abnormalities	NULL
were	NULL
not	NULL
detected	NULL
in	NULL
any	NULL
of	NULL
the	NULL
23	NULL
cases	NULL
tested	NULL
,	NULL
including	NULL
one	NULL
of	NULL
the	NULL
three	NULL
RT-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1318	NULL
M1	NULL
T-	NULL
PBL	NULL
18	NULL
13	NULL
19	NULL
20	NULL
5	NULL
21	NULL
UPN	NULL
14	NULL
12	NULL
4	NULL
_	NULL
10	NULL
13	NULL
11	NULL
POIREL	NULL
ET	NULL
AL	NULL
M3	NULL
UPN	NULL
11	NULL
41	NULL
10	NULL
PBLT	NULL
T+	NULL
«	NULL
414	NULL
pb	NULL
«	NULL
337	NULL
po	NULL
16	NULL
9	NULL
PBL	NULL
«	NULL
4-414	NULL
pb	NULL
Fig	NULL
3	NULL
.	NULL

Detection	NULL
of	NULL
CBFB-MYH11	NULL
fusion	NULL
transcripts	NULL
by	NULL
RT-PCR	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
showing	NULL
the	NULL
presence	NULL
of	NULL
B-actin	NULL
transcripts	NULL
(	NULL
210	NULL
bp	NULL
)	NULL
in	NULL
the	NULL
left-hand	NULL
lane	NULL
and	NULL
C1-M1	NULL
(	NULL
414	NULL
bp	NULL
)	NULL
transcripts	NULL
in	NULL
the	NULL
right-hand	NULL
lane	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
;	NULL
and	NULL
C1-M3	NULL
transcripts	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

T-	NULL
,	NULL
no	NULL
RNA-negative	NULL
control	NULL
;	NULL
PBL	NULL
,	NULL
polyclonal	NULL
lymphocytes	NULL
;	NULL
T+	NULL
,	NULL
type	NULL
C	NULL
(	NULL
nt	NULL
1201	NULL
)	NULL
positive	NULL
control	NULL
(	NULL
337	NULL
bp	NULL
)	NULL
.	NULL

A	NULL
nonspecific	NULL
amplified	NULL
product	NULL
of	NULL
~180	NULL
bp	NULL
was	NULL
frequently	NULL
observed	NULL
with	NULL
this	NULL
primer	NULL
pair	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Seminested	NULL
amplification	NULL
with	NULL
an	NULL
internal	NULL
CBF	NULL
$	NULL
primer	NULL
,	NULL
C2	NULL
.	NULL

The	NULL
C1-M1	NULL
PCR	NULL
products	NULL
were	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
by	NULL
Southern	NULL
blotting	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
P-labeled	NULL
internal	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
C2	NULL
.	NULL

PCR-positive	NULL
cases	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Reevaluation	NULL
of	NULL
the	NULL
karyotypic	NULL
findings	NULL
in	NULL
this	NULL
case	NULL
(	NULL
UPN	NULL
12	NULL
)	NULL
failed	NULL
to	NULL
show	NULL
any	NULL
chromosome	NULL
16	NULL
abnormalities	NULL
in	NULL
the	NULL
35	NULL
mitoses	NULL
analyzed	NULL
,	NULL
although	NULL
both	NULL
R-	NULL
and	NULL
G-banding	NULL
techniques	NULL
were	NULL
performed	NULL
.	NULL

Unfortu-nately	NULL
,	NULL
insufficient	NULL
material	NULL
was	NULL
available	NULL
from	NULL
either	NULL
of	NULL
the	NULL
CBFB-MYH11-positive/karyotype-negative	NULL
cases	NULL
(	NULL
UPN	NULL
3	NULL
and	NULL
12	NULL
)	NULL
for	NULL
FISH	NULL
analysis	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
UPN	NULL
12	NULL
exhibited	NULL
an	NULL
isolated	NULL
trisomy	NULL
22	NULL
,	NULL
known	NULL
to	NULL
be	NULL
frequently	NULL
associated	NULL
with	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
,	NULL
``	NULL
``	NULL
as	NULL
it	NULL
was	NULL
in	NULL
patients	NULL
UPN	NULL
5	NULL
and	NULL
6	NULL
.	NULL

Amplification	NULL
of	NULL
RNA	NULL
from	NULL
a	NULL
second	NULL
vial	NULL
of	NULL
frozen	NULL
blasts	NULL
from	NULL
this	NULL
patient	NULL
and	NULL
from	NULL
an	NULL
apparent	NULL
remission	NULL
bone	NULL
marrow	NULL
sample	NULL
(	NULL
see	NULL
below	NULL
)	NULL
confirmed	NULL
the	NULL
positivity	NULL
in	NULL
this	NULL
case	NULL
.	NULL

Prolonged	NULL
morphologic	NULL
reevaluation	NULL
of	NULL
the	NULL
bone	NULL
marrow	NULL
smears	NULL
from	NULL
the	NULL
three	NULL
RT-PCR-positive	NULL
cases	NULL
showed	NULL
rare	NULL
abnormal	NULL
eosinophilic	NULL
precursors	NULL
in	NULL
UPN	NULL
12	NULL
and	NULL
13	NULL
(	NULL
around	NULL
1/500	NULL
and	NULL
1/200	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
whereas	NULL
no	NULL
abnormal	NULL
eosinophils	NULL
were	NULL
seen	NULL
in	NULL
the	NULL
third	NULL
case	NULL
,	NULL
UPN	NULL
14	NULL
.	NULL

None	NULL
of	NULL
the	NULL
eight	NULL
AML	NULL
M5	NULL
,	NULL
three	NULL
CMML	NULL
,	NULL
or	NULL
the	NULL
AML	NULL
M2	NULL
with	NULL
eosinophilia	NULL
showed	NULL
RT-PCR	NULL
(	NULL
0/13	NULL
)	NULL
or	NULL
karyotypic	NULL
(	NULL
0/9	NULL
)	NULL
abnormalities	NULL
.	NULL

Detection	NULL
of	NULL
chromosome	NULL
16	NULL
abnormalities	NULL
by	NULL
FISH	NULL
.	NULL

-	NULL
To	NULL
confirm	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
inverted	NULL
chromosome	NULL
16	NULL
in	NULL
the	NULL
AML	NULL
M4*	NULL
``	NULL
Eo	NULL
``	NULL
,	NULL
UPN	NULL
11	NULL
,	NULL
we	NULL
performed	NULL
FISH	NULL
analysis	NULL
with	NULL
cosmids	NULL
c40	NULL
and	NULL
c36	NULL
;	NULL
although	NULL
in	NULL
the	NULL
positive	NULL
control	NULL
,	NULL
patient	NULL
UPN	NULL
52	NULL
,	NULL
an	NULL
inversion	NULL
16	NULL
was	NULL
observed	NULL
in	NULL
28/30	NULL
metaphases	NULL
(	NULL
Fig	NULL
2C	NULL
)	NULL
,	NULL
no	NULL
inverted	NULL
chromosomes	NULL
16	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
65	NULL
metaphases	NULL
analyzed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

MYH11	NULL
rearrangement	NULL
by	NULL
Southern	NULL
blotting	NULL
.	NULL

-	NULL
To	NULL
confirm	NULL
the	NULL
finding	NULL
of	NULL
fusion	NULL
transcripts	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
eosinophilia	NULL
and/or	NULL
karyotypic	NULL
chromosome	NULL
16	NULL
dis-ruption	NULL
,	NULL
we	NULL
analyzed	NULL
DNA	NULL
from	NULL
UPN	NULL
3	NULL
,	NULL
12	NULL
,	NULL
and	NULL
14	NULL
and	NULL
from	NULL
a	NULL
classical	NULL
AML	NULL
M4Eo	NULL
with	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
(	NULL
UPN	NULL
52	NULL
)	NULL
.	NULL

High	NULL
molecular-weight	NULL
rearranged	NULL
fragments	NULL
(	NULL
>	NULL
25	NULL
kb	NULL
)	NULL
were	NULL
observed	NULL
in	NULL
EcoRI	NULL
digests	NULL
from	NULL
the	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
-positive	NULL
control	NULL
(	NULL
UPN	NULL
52	NULL
)	NULL
,	NULL
and	NULL
the	NULL
three	NULL
other	NULL
cases	NULL
(	NULL
Fig	NULL
4	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
bands	NULL
observed	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
previously	NULL
described	NULL
by	NULL
van	NULL
der	NULL
Reijden	NULL
in	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
cases	NULL
.	NULL
``	NULL

''	NULL
These	NULL
finding	NULL
confirm	NULL
that	NULL
the	NULL
MYH11	NULL
gene	NULL
is	NULL
indeed	NULL
rearranged	NULL
.	NULL

Detection	NULL
of	NULL
residual	NULL
disease	NULL
by	NULL
RT-PCR	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
sensitivity	NULL
of	NULL
detection	NULL
of	NULL
CBF3	NULL
-MYH11	NULL
transcripts	NULL
,	NULL
we	NULL
diluted	NULL
cDNA	NULL
from	NULL
patient	NULL
UPN	NULL
14	NULL
into	NULL
cDNA	NULL
from	NULL
PBLs	NULL
and	NULL
performed	NULL
single-stage	NULL
or	NULL
seminested	NULL
amplification	NULL
using	NULL
an	NULL
internal	NULL
CBF/	NULL
primer	NULL
,	NULL
C2	NULL
.	NULL

We	NULL
were	NULL
able	NULL
to	NULL
detect	NULL
the	NULL
expected	NULL
band	NULL
at	NULL
a	NULL
10~	NULL
dilution	NULL
with	NULL
the	NULL
external	NULL
primers	NULL
MI-C1	NULL
and	NULL
at	NULL
10~*	NULL
after	NULL
internal	NULL
reamplification	NULL
with	NULL
M1I-C2	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

Parallel	NULL
RT-PCR	NULL
detection	NULL
of	NULL
CBFP-MYH11	NULL
in	NULL
RNA	NULL
extracted	NULL
from	NULL
bone	NULL
marrow	NULL
samples	NULL
taken	NULL
during	NULL
morphologic	NULL
complete	NULL
remission	NULL
was	NULL
performed	NULL
in	NULL
three	NULL
CBF3-MYH11-positive	NULL
patients	NULL
(	NULL
UPN	NULL
8	NULL
,	NULL
10	NULL
,	NULL
12	NULL
)	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
6	NULL
months	NULL
after	NULL
diagnosis	NULL
,	NULL
respectively	NULL
.	NULL

All	NULL
three	NULL
patients	NULL
showed	NULL
residual	NULL
disease	NULL
after	NULL
single-stage	NULL
amplification	NULL
(	NULL
35	NULL
cycles	NULL
)	NULL
and	NULL
either	NULL
hybridization	NULL
with	NULL
an	NULL
internal	NULL
CBF	NULL
oligonucleotide	NULL
probe	NULL
or	NULL
reamplification	NULL
with	NULL
C2	NULL
in	NULL
a	NULL
seminested	NULL
procedure	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
,	NULL
generating	NULL
fragments	NULL
of	NULL
the	NULL
expected	NULL
size	NULL
.	NULL

Amplified	NULL
bands	NULL
were	NULL
also	NULL
visible	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
from	NULL
patients	NULL
UPN	NULL
8	NULL
and	NULL
10	NULL
after	NULL
a	NULL
single	NULL
amplifica-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CHROMOSOME	NULL
16	NULL
CBFG-MYH11	NULL
EcoR1	NULL
x	NULL
°-	NULL
T	NULL
UPN	NULL
3	NULL
UPN	NULL
12	NULL
Fig	NULL
4	NULL
.	NULL

Southern	NULL
blot	NULL
analysis	NULL
with	NULL
a	NULL
MYH11	NULL
cDNA	NULL
probe	NULL
.	NULL

EcoRl-digested	NULL
DNA	NULL
from	NULL
both	NULL
CBFB-MYH11-positive	NULL
cases	NULL
(	NULL
UPN	NULL
3	NULL
and	NULL
13	NULL
)	NULL
show	NULL
a	NULL
>	NULL
25-kb	NULL
rearranged	NULL
fragment	NULL
,	NULL
whereas	NULL
only	NULL
the	NULL
the	NULL
14-kb	NULL
germline	NULL
fragment	NULL
is	NULL
seen	NULL
in	NULL
the	NULL
placental	NULL
germline	NULL
control	NULL
(	NULL
T-	NULL
)	NULL
.	NULL

tion	NULL
.	NULL

A	NULL
fourth	NULL
patient	NULL
,	NULL
UPN	NULL
9	NULL
,	NULL
allografted	NULL
in	NULL
persistent	NULL
aplasia	NULL
after	NULL
second	NULL
relapse	NULL
(	NULL
RT-PCR-positive	NULL
,	NULL
Fig	NULL
5	NULL
,	NULL
sample	NULL
9	NULL
;	NULL
)	NULL
,	NULL
was	NULL
allografted	NULL
but	NULL
remained	NULL
cytopenic	NULL
28	NULL
days	NULL
posttrans-plant	NULL
.	NULL

Biopsy	NULL
showed	NULL
an	NULL
aplastic	NULL
marrow	NULL
,	NULL
but	NULL
bone	NULL
marrow	NULL
aspirates	NULL
showed	NULL
continued	NULL
RT-PCR	NULL
positivity	NULL
(	NULL
Fig	NULL
5-91	NULL
)	NULL
.	NULL

The	NULL
patient	NULL
died	NULL
3	NULL
months	NULL
later	NULL
from	NULL
disseminated	NULL
aspergil-	NULL
T-PBL	NULL
UPN	NULL
8	NULL
12	NULL
9	NULL
~	NULL
1319	NULL
losis	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
the	NULL
increased	NULL
sensitivity	NULL
of	NULL
detection	NULL
of	NULL
RT-PCR	NULL
detection	NULL
when	NULL
compared	NULL
with	NULL
classical	NULL
cytogenetics	NULL
will	NULL
allow	NULL
improved	NULL
follow-up	NULL
of	NULL
patients	NULL
with	NULL
AML	NULL
M4	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
show	NULL
that	NULL
CBFB-MYH11	NULL
fusion	NULL
transcripts	NULL
can	NULL
be	NULL
detected	NULL
,	NULL
not	NULL
only	NULL
in	NULL
virtually	NULL
all	NULL
cases	NULL
of	NULL
typical	NULL
AML	NULL
M4	NULL
Eo	NULL
,	NULL
but	NULL
also	NULL
in	NULL
=~10	NULL
%	NULL
(	NULL
3/29	NULL
)	NULL
of	NULL
AML	NULL
M4	NULL
without	NULL
eosinophilic	NULL
abnormalities	NULL
.	NULL

This	NULL
incidence	NULL
is	NULL
much	NULL
higher	NULL
than	NULL
the	NULL
sporadic	NULL
reports	NULL
of	NULL
karyotypic	NULL
chromosome	NULL
16	NULL
abnormalities	NULL
in	NULL
AML	NULL
M4	NULL
would	NULL
suggest	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
show	NULL
CBF3-MYH11	NULL
fusion	NULL
transcripts	NULL
and	NULL
MYH11	NULL
rearrangement	NULL
in	NULL
at	NULL
least	NULL
one	NULL
case	NULL
reported	NULL
to	NULL
be	NULL
karyotypically	NULL
normal	NULL
.	NULL

Molecular	NULL
screening	NULL
by	NULL
RT-PCR	NULL
of	NULL
53	NULL
myeloid	NULL
malignancies	NULL
showing	NULL
monocytic	NULL
differentiation	NULL
(	NULL
AML	NULL
M4	NULL
,	NULL
AML	NULL
MS	NULL
,	NULL
and	NULL
CMML	NULL
)	NULL
showed	NULL
that	NULL
all	NULL
CBF3-MYH11-positive	NULL
cases	NULL
were	NULL
AML	NULL
M4	NULL
,	NULL
suggesting	NULL
that	NULL
routine	NULL
screening	NULL
is	NULL
not	NULL
justified	NULL
in	NULL
AML	NULL
MS	NULL
,	NULL
although	NULL
formal	NULL
demonstration	NULL
of	NULL
this	NULL
requires	NULL
analysis	NULL
of	NULL
a	NULL
larger	NULL
numbers	NULL
of	NULL
patients	NULL
.	NULL

Of	NULL
the	NULL
41	NULL
AML	NULL
M4	NULL
cases	NULL
analyzed	NULL
,	NULL
27	NULL
%	NULL
(	NULL
11/41	NULL
)	NULL
were	NULL
typical	NULL
AML	NULL
M4Eo	NULL
,	NULL
similar	NULL
to	NULL
previous	NULL
reports	NULL
.	NULL
``	NULL

34	NULL
%	NULL
(	NULL
14/41	NULL
)	NULL
of	NULL
AMLM4	NULL
overall	NULL
were	NULL
CBF3-MYH1	NULL
1	NULL
positive	NULL
,	NULL
suggesting	NULL
that	NULL
routine	NULL
molecular	NULL
screening	NULL
of	NULL
AML	NULL
M4	NULL
will	NULL
pick	NULL
up	NULL
a	NULL
significant	NULL
number	NULL
of	NULL
CBF3-MYH11-positive	NULL
cases	NULL
.	NULL

Because	NULL
21	NULL
%	NULL
(	NULL
3/	NULL
14	NULL
)	NULL
of	NULL
these	NULL
cases	NULL
did	NULL
not	NULL
show	NULL
abnormal	NULL
eosinophils	NULL
,	NULL
such	NULL
procedures	NULL
should	NULL
not	NULL
be	NULL
limited	NULL
to	NULL
AML	NULL
M4Eo	NULL
.	NULL

All	NULL
CBF3-MYH11	NULL
fusion	NULL
transcripts	NULL
detected	NULL
in	NULL
this	NULL
study	NULL
involved	NULL
the	NULL
predominant	NULL
MYH11	NULL
breakpoint	NULL
(	NULL
type	NULL
A	NULL
)	NULL
,	NULL
previously	NULL
described	NULL
to	NULL
occur	NULL
in	NULL
80	NULL
%	NULL
of	NULL
36	NULL
cases	NULL
with	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
or	NULL
t	NULL
(	NULL
16	NULL
;	NULL
16	NULL
)	NULL
.	NULL
'	NULL

''	NULL
The	NULL
remaining	NULL
20	NULL
%	NULL
of	NULL
cases	NULL
shown	NULL
by	NULL
Claxton	NULL
et	NULL
al	NULL
involved	NULL
three	NULL
variant	NULL
MYH11	NULL
breakpoints	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
detectable	NULL
in	NULL
the	NULL
present	NULL
series	NULL
as	NULL
larger	NULL
amplified	NULL
fragments	NULL
with	NULL
the	NULL
M1	NULL
oligonucleotide	NULL
(	NULL
type	NULL
B	NULL
)	NULL
or	NULL
with	NULL
a	NULL
second	NULL
upstream	NULL
oligonucleotide	NULL
,	NULL
M3	NULL
(	NULL
types	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
variant	NULL
breakpoints	NULL
is	NULL
probably	NULL
caused	NULL
by	NULL
the	NULL
limited	NULL
number	NULL
of	NULL
M4Eo	NULL
cases	NULL
analyzed	NULL
.	NULL

False-negative	NULL
results	NULL
are	NULL
unlikely	NULL
because	NULL
(	NULL
1	NULL
)	NULL
all	NULL
patients	NULL
with	NULL
typical	NULL
M4Eo	NULL
were	NULL
RT-PCR	NULL
positive	NULL
;	NULL
(	NULL
2	NULL
)	NULL
amplification	NULL
with	NULL
C1	NULL
and	NULL
M3	NULL
primers	NULL
UPN	NULL
14	NULL
-2	NULL
0-8	NULL
~4	NULL
0-5	NULL
«	NULL
-	NULL
322	NULL
pb	NULL
Fig	NULL
5	NULL
.	NULL

Detection	NULL
of	NULL
residual	NULL
disease	NULL
by	NULL
RT-PCR	NULL
with	NULL
type	NULL
A	NULL
CBFB-MYH11	NULL
transcripts	NULL
in	NULL
UPN	NULL
8	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
.	NULL

Seminested	NULL
amplification	NULL
with	NULL
an	NULL
internal	NULL
CBFB	NULL
primer	NULL
,	NULL
C2	NULL
,	NULL
of	NULL
remission	NULL
bone	NULL
marrow	NULL
samples	NULL
from	NULL
UPN	NULL
8	NULL
and	NULL
12	NULL
and	NULL
postallograft	NULL
aplasia	NULL
samples	NULL
from	NULL
UPN	NULL
9.	NULL
cDNA	NULL
from	NULL
UPN	NULL
14	NULL
was	NULL
diluted	NULL
into	NULL
cDNA	NULL
from	NULL
PBLs	NULL
at	NULL
10~	NULL
'	NULL
to	NULL
10~°	NULL
to	NULL
determine	NULL
the	NULL
sensitivity	NULL
of	NULL
detection	NULL
.	NULL

T-	NULL
,	NULL
no	NULL
RNA-negative	NULL
control	NULL
:	NULL
PBL	NULL
,	NULL
polyclonal	NULL
normal	NULL
RNA	NULL
control	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1320	NULL
of	NULL
a	NULL
cDNA	NULL
transcribed	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
a	NULL
type	NULL
C	NULL
breakpoint	NULL
generated	NULL
the	NULL
expected	NULL
transcript	NULL
;	NULL
(	NULL
3	NULL
)	NULL
amplification	NULL
of	NULL
RT-PCR-negative	NULL
cases	NULL
with	NULL
the	NULL
Ml	NULL
and	NULL
primers	NULL
under	NULL
conditions	NULL
favoring	NULL
the	NULL
formation	NULL
of	NULL
longer	NULL
PCR	NULL
fragments	NULL
(	NULL
prolongation	NULL
of	NULL
the	NULL
elongation	NULL
step	NULL
to	NULL
3	NULL
minutes	NULL
)	NULL
failed	NULL
to	NULL
show	NULL
any	NULL
larger	NULL
bands	NULL
of	NULL
the	NULL
expected	NULL
size	NULL
,	NULL
including	NULL
after	NULL
hybridization	NULL
with	NULL
an	NULL
internal	NULL
CBFS	NULL
probe	NULL
.	NULL

All	NULL
11	NULL
typical	NULL
AML	NULL
MA4Eo	NULL
were	NULL
CBFG-MYH11	NULL
positive	NULL
,	NULL
including	NULL
one	NULL
case	NULL
reported	NULL
to	NULL
be	NULL
karyotypically	NULL
normal	NULL
on	NULL
a	NULL
limited	NULL
numder	NULL
of	NULL
metaphases	NULL
,	NULL
thus	NULL
confirming	NULL
the	NULL
results	NULL
of	NULL
Claxton	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
We	NULL
also	NULL
show	NULL
that	NULL
complex	NULL
chromosome	NULL
16	NULL
abnormalities	NULL
,	NULL
as	NULL
found	NULL
in	NULL
UPN10	NULL
,	NULL
can	NULL
recreate	NULL
the	NULL
same	NULL
fusion	NULL
transcript	NULL
as	NULL
classical	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
or	NULL
t	NULL
(	NULL
16	NULL
;	NULL
16	NULL
)	NULL
.	NULL

The	NULL
single	NULL
case	NULL
showing	NULL
distinctive	NULL
eosinophil	NULL
abnormalities	NULL
(	NULL
UPN	NULL
11	NULL
)	NULL
was	NULL
CBFG-MYH11	NULL
negative	NULL
and	NULL
did	NULL
not	NULL
show	NULL
any	NULL
evident	NULL
chromosome	NULL
16	NULL
abnormalities	NULL
,	NULL
even	NULL
by	NULL
FISH	NULL
analysis	NULL
with	NULL
chromosome	NULL
16p	NULL
probes	NULL
.	NULL

The	NULL
distinct	NULL
nature	NULL
of	NULL
these	NULL
morphologic	NULL
abnormalities	NULL
had	NULL
been	NULL
documented	NULL
before	NULL
obtaining	NULL
either	NULL
the	NULL
karyotype	NULL
or	NULL
PCR	NULL
results	NULL
and	NULL
the	NULL
case	NULL
had	NULL
been	NULL
classified	NULL
as	NULL
AML	NULL
M4	NULL
with	NULL
atypical	NULL
abnormal	NULL
eosinophils	NULL
rather	NULL
than	NULL
as	NULL
M4Eo	NULL
.	NULL

This	NULL
case	NULL
suggests	NULL
that	NULL
AML	NULL
M4	NULL
with	NULL
eosinophilia	NULL
but	NULL
without	NULL
the	NULL
typical	NULL
morphologic	NULL
features	NULL
of	NULL
AML	NULL
MA4Eo	NULL
may	NULL
represent	NULL
a	NULL
distinct	NULL
subtype	NULL
of	NULL
AML	NULL
M4	NULL
involving	NULL
either	NULL
distinct	NULL
breakpoints	NULL
in	NULL
MYH11	NULL
and/or	NULL
CBFL	NULL
or	NULL
distinct	NULL
genetic	NULL
abnormalities	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
karyotypic	NULL
and	NULL
FISH	NULL
abnormalities	NULL
are	NULL
in	NULL
favor	NULL
of	NULL
the	NULL
latter	NULL
.	NULL

In	NULL
practical	NULL
terms	NULL
,	NULL
it	NULL
shows	NULL
that	NULL
it	NULL
is	NULL
the	NULL
presence	NULL
of	NULL
certain	NULL
qualitative	NULL
abnormalities	NULL
of	NULL
eosinophil	NULL
maturation	NULL
which	NULL
correlates	NULL
most	NULL
closely	NULL
with	NULL
chromosome	NULL
16	NULL
defects	NULL
.	NULL

Three	NULL
of	NULL
the	NULL
29	NULL
AML	NULL
M4	NULL
cases	NULL
without	NULL
eosinophilic	NULL
abnormalities	NULL
(	NULL
UPN	NULL
12	NULL
,	NULL
13	NULL
,	NULL
14	NULL
)	NULL
showed	NULL
a	NULL
CBFS-MYH11	NULL
fusion	NULL
transcript	NULL
.	NULL

The	NULL
fusion	NULL
transcript	NULL
was	NULL
confirmed	NULL
by	NULL
Southern	NULL
blotting	NULL
of	NULL
a	NULL
MYH11	NULL
rearrangement	NULL
in	NULL
two	NULL
cases	NULL
(	NULL
UPN	NULL
12	NULL
and	NULL
14	NULL
)	NULL
.	NULL

Although	NULL
morphologic	NULL
review	NULL
in	NULL
the	NULL
light	NULL
of	NULL
the	NULL
RT-PCR	NULL
results	NULL
showed	NULL
very	NULL
rare	NULL
abnormal	NULL
eosinophils	NULL
in	NULL
cases	NULL
UPN	NULL
12	NULL
and	NULL
UPN	NULL
13	NULL
,	NULL
but	NULL
not	NULL
in	NULL
UPN	NULL
14	NULL
,	NULL
such	NULL
rare	NULL
events	NULL
have	NULL
little	NULL
value	NULL
in	NULL
routine	NULL
use	NULL
for	NULL
classification	NULL
purposes	NULL
.	NULL

Sporadic	NULL
reports	NULL
of	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
in	NULL
AML	NULL
M4	NULL
exist	NULL
but	NULL
occur	NULL
too	NULL
infrequently	NULL
to	NULL
allow	NULL
accurate	NULL
assessment	NULL
of	NULL
their	NULL
incidence	NULL
.	NULL
``	NULL

The	NULL
10	NULL
%	NULL
incidence	NULL
reported	NULL
here	NULL
suggests	NULL
its	NULL
frequency	NULL
may	NULL
have	NULL
been	NULL
underestimated	NULL
.	NULL

The	NULL
well-recog-nized	NULL
association	NULL
of	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
/t	NULL
(	NULL
16	NULL
;	NULL
16	NULL
)	NULL
and	NULL
M4Eo	NULL
may	NULL
introduce	NULL
a	NULL
slight	NULL
bias	NULL
in	NULL
both	NULL
the	NULL
frequency	NULL
of	NULL
karyotype	NULL
analysis	NULL
and	NULL
the	NULL
effort	NULL
expended	NULL
in	NULL
searching	NULL
for	NULL
chromosome	NULL
16	NULL
abnormalities	NULL
once	NULL
typical	NULL
eosinophil	NULL
abnormalities	NULL
have	NULL
been	NULL
detected	NULL
.	NULL

Such	NULL
a	NULL
bias	NULL
would	NULL
tend	NULL
to	NULL
underestimate	NULL
the	NULL
number	NULL
of	NULL
cases	NULL
with	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
in	NULL
the	NULL
group	NULL
without	NULL
eosinophil	NULL
abnormalities	NULL
.	NULL

The	NULL
CBFS-MYH11	NULL
RT-PCR	NULL
results	NULL
presented	NULL
here	NULL
are	NULL
in	NULL
keeping	NULL
with	NULL
this	NULL
possibility	NULL
.	NULL

Analysis	NULL
of	NULL
a	NULL
larger	NULL
number	NULL
of	NULL
AML	NULL
M4	NULL
by	NULL
either	NULL
RT-PCR	NULL
or	NULL
FISH	NULL
with	NULL
appropriate	NULL
probes	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
determine	NULL
whether	NULL
this	NULL
incidence	NULL
is	NULL
representative	NULL
.	NULL

If	NULL
this	NULL
proves	NULL
to	NULL
be	NULL
the	NULL
case	NULL
,	NULL
it	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
whether	NULL
it	NULL
is	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
fusion	NULL
transcript	NULL
or	NULL
the	NULL
eosinophil	NULL
abnormalities	NULL
which	NULL
confer	NULL
an	NULL
improved	NULL
prognosis	NULL
.	NULL

Two	NULL
patients	NULL
,	NULL
one	NULL
AML	NULL
M4Eo	NULL
(	NULL
UPN	NULL
3	NULL
)	NULL
and	NULL
one	NULL
AML	NULL
M4	NULL
(	NULL
UPN	NULL
12	NULL
)	NULL
,	NULL
considered	NULL
not	NULL
to	NULL
have	NULL
chromosome	NULL
16	NULL
abnor-	NULL
POIREL	NULL
ET	NULL
AL	NULL
malities	NULL
by	NULL
standard	NULL
karyotype	NULL
analysis	NULL
showed	NULL
MYH11	NULL
fusion	NULL
transcripts	NULL
.	NULL

In	NULL
the	NULL
first	NULL
case	NULL
,	NULL
only	NULL
4	NULL
metaphases	NULL
were	NULL
analyzable	NULL
and	NULL
the	NULL
value	NULL
of	NULL
this	NULL
negative	NULL
result	NULL
is	NULL
therefore	NULL
limited	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
35	NULL
mitoses	NULL
were	NULL
analyzed	NULL
by	NULL
G	NULL
banding	NULL
in	NULL
UPN	NULL
12	NULL
and	NULL
both	NULL
chromosome	NULL
16s	NULL
were	NULL
considered	NULL
normal	NULL
,	NULL
both	NULL
initially	NULL
and	NULL
after	NULL
review	NULL
in	NULL
light	NULL
of	NULL
the	NULL
PCR	NULL
findings	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
case	NULL
showed	NULL
an	NULL
isolated	NULL
trisomy	NULL
22	NULL
.	NULL

Trisomy	NULL
22	NULL
is	NULL
a	NULL
rare	NULL
finding	NULL
in	NULL
AML	NULL
,	NULL
occurring	NULL
in	NULL
only	NULL
2	NULL
%	NULL
of	NULL
cases	NULL
,	NULL
but	NULL
is	NULL
associated	NULL
with	NULL
an	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
in	NULL
~45	NULL
%	NULL
of	NULL
cases	NULL
.	NULL
``	NULL

''	NULL
The	NULL
RT-PCR	NULL
result	NULL
was	NULL
confirmed	NULL
in	NULL
both	NULL
cases	NULL
by	NULL
demonstration	NULL
of	NULL
MYH11	NULL
rearrangement	NULL
by	NULL
Southern	NULL
and	NULL
residual	NULL
positivity	NULL
in	NULL
UPN	NULL
12	NULL
in	NULL
apparent	NULL
complete	NULL
remission	NULL
.	NULL

Molecular	NULL
detection	NULL
of	NULL
tumor-specific	NULL
fusion	NULL
transcripts	NULL
in	NULL
karyotype-negative	NULL
cases	NULL
at	NULL
diagnosis	NULL
is	NULL
well	NULL
recognized	NULL
with	NULL
several	NULL
other	NULL
recurrent	NULL
chromosomal	NULL
trans-locations	NULL
,	NULL
including	NULL
BCR-ABL	NULL
and	NULL
t	NULL
(	NULL
9	NULL
;	NULL
22	NULL
)	NULL
,	NULL
``	NULL
'	NULL
E2A-PBX1	NULL
and	NULL
19	NULL
)	NULL
,	NULL
ETO-AML1	NULL
and	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
``	NULL
``	NULL
*	NULL
and	NULL
MLL	NULL
and	NULL
abnormalities	NULL
of	NULL
chromosome	NULL
11423	NULL
.	NULL
``	NULL

The	NULL
frequency	NULL
with	NULL
which	NULL
such	NULL
discrepancies	NULL
exist	NULL
correlates	NULL
with	NULL
the	NULL
ability	NULL
to	NULL
obtain	NULL
adequate	NULL
metaphases	NULL
,	NULL
the	NULL
coexistence	NULL
of	NULL
normal	NULL
metaphases	NULL
and	NULL
the	NULL
difficulty	NULL
of	NULL
karyotypic	NULL
detection	NULL
of	NULL
certain	NULL
chromosomal	NULL
rearrangements	NULL
.	NULL

The	NULL
latter	NULL
represents	NULL
a	NULL
particular	NULL
problem	NULL
in	NULL
detection	NULL
of	NULL
chromosome	NULL
16	NULL
abnormalities	NULL
,	NULL
especially	NULL
when	NULL
R-banding	NULL
techniques	NULL
are	NULL
used	NULL
.	NULL
``	NULL

While	NULL
the	NULL
use	NULL
of	NULL
whole	NULL
chromosome	NULL
16	NULL
paints	NULL
will	NULL
not	NULL
improve	NULL
karyotypic	NULL
detection	NULL
of	NULL
these	NULL
abnormalities	NULL
,	NULL
cosmid	NULL
or	NULL
YAC	NULL
probes	NULL
specific	NULL
for	NULL
the	NULL
16p13	NULL
or	NULL
16q22	NULL
breakpoints	NULL
will	NULL
provide	NULL
useful	NULL
methods	NULL
of	NULL
confirmation	NULL
of	NULL
CBFS-MYH11-positive	NULL
,	NULL
karyotype-negative	NULL
cases	NULL
,	NULL
.	NULL

``	NULL
**	NULL
``	NULL
Unfortu-nately	NULL
,	NULL
no	NULL
mitoses	NULL
were	NULL
available	NULL
for	NULL
FISH	NULL
analysis	NULL
from	NULL
either	NULL
UPN	NULL
3	NULL
or	NULL
12	NULL
.	NULL

Such	NULL
techniques	NULL
will	NULL
also	NULL
be	NULL
useful	NULL
in	NULL
the	NULL
analysis	NULL
of	NULL
complex	NULL
chromosome	NULL
16	NULL
abnormalities	NULL
,	NULL
as	NULL
in	NULL
the	NULL
case	NULL
of	NULL
UPN	NULL
10	NULL
from	NULL
this	NULL
series	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
standard	NULL
karyotype	NULL
analysis	NULL
may	NULL
underestimate	NULL
the	NULL
incidence	NULL
of	NULL
chromosome	NULL
abnormalities	NULL
and	NULL
that	NULL
it	NULL
should	NULL
be	NULL
complemented	NULL
by	NULL
either	NULL
FISH	NULL
or	NULL
RT-PCR	NULL
analysis	NULL
.	NULL

Analysis	NULL
of	NULL
dilutions	NULL
of	NULL
RNA	NULL
from	NULL
diagnostic	NULL
samples	NULL
showed	NULL
that	NULL
this	NULL
technique	NULL
permits	NULL
the	NULL
detection	NULL
of	NULL
minority	NULL
clonal	NULL
populations	NULL
when	NULL
they	NULL
represent	NULL
as	NULL
little	NULL
as	NULL
10~*	NULL
of	NULL
the	NULL
sample	NULL
analyzed	NULL
in	NULL
nested	NULL
PCR	NULL
,	NULL
thus	NULL
showing	NULL
a	NULL
sensitivity	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
Claxton	NULL
et	NULL
al	NULL
.	NULL
'	NULL

''	NULL
In	NULL
keeping	NULL
with	NULL
this	NULL
,	NULL
all	NULL
three	NULL
patients	NULL
tested	NULL
,	NULL
albeit	NULL
early	NULL
,	NULL
in	NULL
complete	NULL
hematologic	NULL
remission	NULL
remained	NULL
RT-PCR	NULL
positive	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
evaluation	NULL
of	NULL
such	NULL
a	NULL
system	NULL
for	NULL
the	NULL
follow-up	NULL
of	NULL
patients	NULL
is	NULL
merited	NULL
.	NULL

The	NULL
coding	NULL
sequence	NULL
remains	NULL
largely	NULL
intact	NULL
in	NULL
the	NULL
CBFG-MYH11	NULL
fusion	NULL
transcript	NULL
,	NULL
losing	NULL
only	NULL
the	NULL
3	NULL
'	NULL
part	NULL
that	NULL
codes	NULL
for	NULL
the	NULL
last	NULL
17	NULL
amino	NULL
acids	NULL
.	NULL

CBF/	NULL
#	NULL
forms	NULL
a	NULL
heterodimer	NULL
with	NULL
CBFa/AML1	NULL
,	NULL
involved	NULL
in	NULL
the	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
,	NULL
associated	NULL
predominantly	NULL
with	NULL
AML	NULL
M2	NULL
,	NULL
but	NULL
in	NULL
the	NULL
remaining	NULL
10	NULL
%	NULL
of	NULL
cases	NULL
with	NULL
AML	NULL
M4	NULL
.	NULL
``	NULL

The	NULL
murine	NULL
homologue	NULL
of	NULL
CBF	NULL
,	NULL
PEBp2/	NULL
$	NULL
,	NULL
does	NULL
not	NULL
bind	NULL
directly	NULL
to	NULL
DNA	NULL
but	NULL
rather	NULL
increases	NULL
the	NULL
intrinsic	NULL
binding	NULL
affinity	NULL
of	NULL
AMLI/CBFa	NULL
to	NULL
its	NULL
target	NULL
DNA	NULL
sequence	NULL
by	NULL
decreasing	NULL
its	NULL
dissociation	NULL
rate	NULL
'*	NULL
.	NULL

CBF	NULL
binds	NULL
to	NULL
the	NULL
enhancers	NULL
of	NULL
various	NULL
T	NULL
lymphotropic	NULL
murine	NULL
leukemia	NULL
viruses	NULL
``	NULL
and	NULL
to	NULL
similar	NULL
motifs	NULL
in	NULL
the	NULL
enhancers	NULL
of	NULL
several	NULL
genes	NULL
specifically	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
including	NULL
CD2	NULL
,	NULL
``	NULL
CD3e	NULL
and	NULL
the	NULL
TCRa	NULL
``	NULL
,	NULL
TCRy	NULL
``	NULL
®	NULL
and	NULL
TCR8	NULL
``	NULL
genes	NULL
,	NULL
where	NULL
mutations	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
lead	NULL
to	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CHROMOSOME	NULL
16	NULL
CBFS-MYH11	NULL
a	NULL
reduction	NULL
in	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
TCR	NULL
#	NULL
and	NULL
TCRA	NULL
genes	NULL
.	NULL
``	NULL

In	NULL
this	NULL
context	NULL
,	NULL
it	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
one	NULL
case	NULL
(	NULL
UPN	NULL
14	NULL
)	NULL
of	NULL
CBF3-MYH11-positive	NULL
AML	NULL
M4	NULL
later	NULL
developed	NULL
an	NULL
angiocentric	NULL
T-cell	NULL
lymphoma	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
.	NULL

*	NULL
'	NULL
Angiocentric	NULL
T-cell	NULL
lymphomas	NULL
are	NULL
characterized	NULL
by	NULL
a	NULL
polymorphic	NULL
infiltrate	NULL
,	NULL
often	NULL
including	NULL
a	NULL
substantial	NULL
eosinophilic	NULL
component	NULL
,	NULL
which	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
at	NULL
least	NULL
partly	NULL
caused	NULL
by	NULL
the	NULL
production	NULL
of	NULL
various	NULL
cytokines	NULL
by	NULL
the	NULL
T-cell	NULL
clone	NULL
,	NULL
in	NULL
particular	NULL
interleukin-5	NULL
.	NULL

*	NULL
The	NULL
association	NULL
between	NULL
eosinophilia	NULL
and	NULL
T	NULL
lymphoproliferative	NULL
disorders	NULL
is	NULL
well	NULL
rec-ognized	NULL
.	NULL
``	NULL

The	NULL
demonstration	NULL
of	NULL
deregulation	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
important	NULL
in	NULL
T-cell	NULL
development	NULL
and	NULL
function	NULL
in	NULL
a	NULL
myeloid	NULL
malignancy	NULL
characterized	NULL
by	NULL
abnormal	NULL
eosinophil	NULL
development	NULL
and	NULL
usually	NULL
by	NULL
eosinophilia	NULL
raises	NULL
several	NULL
interesting	NULL
questions	NULL
.	NULL

Further	NULL
studies	NULL
of	NULL
the	NULL
functional	NULL
consequences	NULL
of	NULL
the	NULL
CBFP-MYH11	NULL
fusion	NULL
transcript	NULL
are	NULL
clearly	NULL
required	NULL
.	NULL

The	NULL
recent	NULL
demonstration	NULL
that	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
two	NULL
myeloid	NULL
specific	NULL
genes	NULL
,	NULL
myeloperoxidase	NULL
and	NULL
neutrophil	NULL
elastase	NULL
,	NULL
suggest	NULL
one	NULL
interesting	NULL
possible	NULL
di-rection	NULL
.	NULL
``	NULL

In	NULL
the	NULL
meantime	NULL
,	NULL
the	NULL
ability	NULL
to	NULL
detect	NULL
it	NULL
by	NULL
RT-PCR	NULL
will	NULL
refine	NULL
our	NULL
ability	NULL
to	NULL
evaluate	NULL
prognosis	NULL
and	NULL
response	NULL
to	NULL
treatment	NULL
in	NULL
patients	NULL
with	NULL
AML	NULL
M4	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
J.	NULL
Hébert	NULL
and	NULL
F.	NULL
Sigaux	NULL
(	NULL
Hopital	NULL
Saint-Louis	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
type	NULL
C	NULL
positive	NULL
control	NULL
;	NULL
J.G	NULL
.	NULL

Dauwerse	NULL
and	NULL
B.A	NULL
.	NULL

van	NULL
der	NULL
Reijden	NULL
for	NULL
the	NULL
MYH11	NULL
cDNA	NULL
probe	NULL
and	NULL
the	NULL
c36	NULL
and	NULL
c40	NULL
cosmids	NULL
;	NULL
G.	NULL
Plessis	NULL
(	NULL
Hopital	NULL
Clémenceau	NULL
,	NULL
Caen	NULL
,	NULL
France	NULL
)	NULL
,	NULL
F.	NULL
Viguig	NULL
,	NULL
and	NULL
S.	NULL
Ramon	NULL
(	NULL
Hopital	NULL
Hotel-Dieu	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
for	NULL
cytogenetic	NULL
analysis	NULL
;	NULL
and	NULL
B.	NULL
Varet	NULL
(	NULL
Hopital	NULL
Necker-Enfants	NULL
Malades	NULL
,	NULL
Paris	NULL
)	NULL
and	NULL
M.	NULL
Leporrier	NULL
(	NULL
Hopital	NULL
Clémenceau	NULL
,	NULL
Caen	NULL
)	NULL
for	NULL
the	NULL
submission	NULL
of	NULL
clinical	NULL
material	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Loffler	NULL
H	NULL
:	NULL
Indications	NULL
and	NULL
limits	NULL
of	NULL
cytochemistry	NULL
in	NULL
acute	NULL
leukemia	NULL
.	NULL

Methodology	NULL
and	NULL
results	NULL
of	NULL
clinical	NULL
trials	NULL
in	NULL
acute	NULL
leuke-mia	NULL
,	NULL
in	NULL
Mathé	NULL
G	NULL
,	NULL
Pouillart	NULL
P	NULL
,	NULL
Schwarzenberg	NULL
L	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Recent	NULL
Results	NULL
in	NULL
Cancer	NULL
Research	NULL
.	NULL

Berlin	NULL
,	NULL
Germany	NULL
,	NULL
Springer-Verlag	NULL
,	NULL
1973	NULL
,	NULL
p	NULL
57	NULL
2	NULL
.	NULL

Bennett	NULL
JM	NULL
,	NULL
Catovsky	NULL
D	NULL
,	NULL
Daniel	NULL
MT	NULL
,	NULL
Flandrin	NULL
G	NULL
,	NULL
Galton	NULL
DAG	NULL
,	NULL
Gralnick	NULL
HR	NULL
,	NULL
Sultan	NULL
C	NULL
:	NULL
Proposed	NULL
revised	NULL
criteria	NULL
for	NULL
the	NULL
classification	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
:	NULL
A	NULL
report	NULL
of	NULL
the	NULL
French-	NULL
American-British	NULL
cooperative	NULL
group	NULL
.	NULL

Ann	NULL
Intern	NULL
Med	NULL
103:626	NULL
,	NULL
1985	NULL
3	NULL
.	NULL

Larson	NULL
RA	NULL
,	NULL
Williams	NULL
SF	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
,	NULL
Bitter	NULL
MA	NULL
,	NULL
Vardiman	NULL
JW	NULL
,	NULL
Rowley	NULL
JD	NULL
:	NULL
Acute	NULL
myelomonocytic	NULL
meukemia	NULL
with	NULL
abnormal	NULL
eosinophils	NULL
and	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
and	NULL
t	NULL
(	NULL
16	NULL
;	NULL
16	NULL
)	NULL
has	NULL
a	NULL
favorable	NULL
prognosis	NULL
.	NULL

Blood	NULL
68:1242	NULL
,	NULL
1986	NULL
4	NULL
.	NULL

Campbell	NULL
LJ	NULL
,	NULL
Challis	NULL
J	NULL
,	NULL
Fok	NULL
T	NULL
,	NULL
Grason	NULL
OM	NULL
:	NULL
Chromosome	NULL
16	NULL
abnormalities	NULL
associated	NULL
with	NULL
myeloid	NULL
malignancies	NULL
.	NULL

Genes	NULL
,	NULL
Chromosomes	NULL
and	NULL
Cancer	NULL
3:55	NULL
,	NULL
1991	NULL
5	NULL
.	NULL

Betts	NULL
DR	NULL
,	NULL
Rohatiner	NULL
AZS	NULL
,	NULL
Evans	NULL
ML	NULL
,	NULL
Rassam	NULL
SMB	NULL
,	NULL
Lister	NULL
TA	NULL
,	NULL
Gibbons	NULL
B	NULL
:	NULL
Abnormalities	NULL
of	NULL
chromosome	NULL
16q	NULL
in	NULL
myeloid	NULL
ma-lignancy	NULL
:	NULL
14	NULL
new	NULL
cases	NULL
and	NULL
a	NULL
review	NULL
of	NULL
the	NULL
literature	NULL
.	NULL

Leukemia	NULL
6:1250	NULL
,	NULL
1992	NULL
6	NULL
.	NULL

Le	NULL
Beau	NULL
M	NULL
,	NULL
Larson	NULL
RA	NULL
,	NULL
Bitter	NULL
MA	NULL
,	NULL
Vardiman	NULL
JW	NULL
,	NULL
Golomb	NULL
HM	NULL
,	NULL
Rowley	NULL
JD	NULL
:	NULL
Association	NULL
of	NULL
an	NULL
inversion	NULL
of	NULL
chromosome	NULL
16	NULL
with	NULL
abnormal	NULL
marrow	NULL
eosinophils	NULL
in	NULL
acute	NULL
myelomonocytic	NULL
leukemia	NULL
:	NULL
A	NULL
unique	NULL
cytogenetic-clinicopathological	NULL
association	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
309:630	NULL
,	NULL
1983	NULL
7	NULL
.	NULL

Hogge	NULL
DE	NULL
,	NULL
Misawa	NULL
S	NULL
,	NULL
Parsa	NULL
NZ	NULL
,	NULL
Pollak	NULL
A	NULL
,	NULL
Testa	NULL
JR	NULL
:	NULL
Abnormalities	NULL
of	NULL
chromosome	NULL
16	NULL
in	NULL
association	NULL
with	NULL
acute	NULL
myelomonocytic	NULL
leukemia	NULL
and	NULL
dysplastic	NULL
bone	NULL
marrow	NULL
eosinophils	NULL
.	NULL

J	NULL
Clin	NULL
Oncol	NULL
2:550	NULL
,	NULL
1984	NULL
1321	NULL
8	NULL
.	NULL

Harth	NULL
H	NULL
,	NULL
Pees	NULL
H	NULL
,	NULL
Zank	NULL
IH	NULL
:	NULL
Acute	NULL
myelomonocytic	NULL
leukemia	NULL
(	NULL
M4	NULL
)	NULL
with	NULL
eosinophilia	NULL
:	NULL
Problems	NULL
concerning	NULL
chromosome	NULL
16	NULL
abnormality	NULL
.	NULL

Cancer	NULL
Genet	NULL
Cytogenet	NULL
23:127	NULL
,	NULL
1986	NULL
9	NULL
.	NULL

Bernard	NULL
P	NULL
,	NULL
Dachary	NULL
D	NULL
,	NULL
Reiffers	NULL
J	NULL
,	NULL
Marit	NULL
G	NULL
,	NULL
Wen	NULL
Z	NULL
,	NULL
Jonveaux	NULL
P	NULL
,	NULL
David	NULL
B	NULL
,	NULL
Lacombe	NULL
F	NULL
,	NULL
Broustet	NULL
A	NULL
:	NULL
Acute	NULL
non	NULL
lymphocytic	NULL
leukae-mia	NULL
with	NULL
marrow	NULL
eosinophilia	NULL
and	NULL
chromosome	NULL
16	NULL
abnormality	NULL
.	NULL

Leukemia	NULL
3:740	NULL
,	NULL
1989	NULL
10	NULL
.	NULL

Claxton	NULL
DF	NULL
,	NULL
Liu	NULL
P	NULL
,	NULL
Hsu	NULL
HB	NULL
,	NULL
Marlton	NULL
P	NULL
,	NULL
Hester	NULL
J	NULL
,	NULL
Collins	NULL
F	NULL
,	NULL
Deisseroth	NULL
AB	NULL
,	NULL
Rowley	NULL
JD	NULL
,	NULL
Siciliano	NULL
MJ	NULL
:	NULL
Detection	NULL
of	NULL
fusion	NULL
transcripts	NULL
generated	NULL
by	NULL
the	NULL
inversion	NULL
16	NULL
chromsome	NULL
in	NULL
acute	NULL
myelo-geneous	NULL
leukemia	NULL
.	NULL

Blood	NULL
83:1750	NULL
,	NULL
1994	NULL
11	NULL
.	NULL

Narayanan	NULL
MN	NULL
,	NULL
Geary	NULL
CG	NULL
,	NULL
Harrison	NULL
CJ	NULL
,	NULL
Cinkotai	NULL
KI	NULL
,	NULL
Lewis	NULL
MJ	NULL
:	NULL
Three	NULL
cases	NULL
of	NULL
the	NULL
myelodysplastic	NULL
syndrome	NULL
with	NULL
pericenric	NULL
inversion	NULL
of	NULL
chromosome	NULL
16	NULL
.	NULL

Br	NULL
J	NULL
Haemat	NULL
85:217	NULL
,	NULL
1993	NULL
12	NULL
.	NULL

Liu	NULL
P	NULL
,	NULL
Tarle	NULL
SA	NULL
,	NULL
Hajra	NULL
A	NULL
,	NULL
Claxton	NULL
DF	NULL
,	NULL
Marlton	NULL
P	NULL
,	NULL
Freedman	NULL
M	NULL
,	NULL
Siciliano	NULL
MJ	NULL
,	NULL
Collins	NULL
FS	NULL
:	NULL
Fusion	NULL
between	NULL
transcription	NULL
factor	NULL
CBF-G/PEBP-2-G	NULL
and	NULL
a	NULL
myosin	NULL
heavy	NULL
chain	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Science	NULL
261:1041	NULL
,	NULL
1993	NULL
13	NULL
.	NULL

Wang	NULL
S	NULL
,	NULL
Speck	NULL
NA	NULL
:	NULL
Purification	NULL
of	NULL
core-binding	NULL
factor	NULL
,	NULL
a	NULL
protein	NULL
that	NULL
binds	NULL
the	NULL
conserved	NULL
core	NULL
site	NULL
in	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancers	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
12:89	NULL
,	NULL
1992	NULL
14	NULL
.	NULL

Ho	NULL
IC	NULL
,	NULL
Yang	NULL
LH	NULL
,	NULL
Morle	NULL
G	NULL
,	NULL
Leiden	NULL
JM	NULL
:	NULL
A	NULL
T-cell-specific	NULL
transcriptional	NULL
enhancer	NULL
element	NULL
3	NULL
'	NULL
of	NULL
Ca	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
recep-tora	NULL
locus	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:6714	NULL
,	NULL
1989	NULL
15	NULL
.	NULL

Gottschalk	NULL
LR	NULL
,	NULL
Leiden	NULL
JM	NULL
:	NULL
Identification	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
beta	NULL
gene	NULL
transcriptional	NULL
enhancer	NULL
:	NULL
Common	NULL
nuclear	NULL
proteins	NULL
interact	NULL
with	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
a	NULL
and	NULL
3	NULL
genes	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:5486	NULL
,	NULL
1990	NULL
16	NULL
.	NULL

Kappes	NULL
DJ	NULL
,	NULL
Browne	NULL
CP	NULL
,	NULL
Tonegawa	NULL
S	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
T-cell-specific	NULL
enhancer	NULL
at	NULL
the	NULL
locus	NULL
encoding	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
y	NULL
chain	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:2204	NULL
,	NULL
1991	NULL
17	NULL
.	NULL

Redondo	NULL
JM	NULL
,	NULL
Pfohl	NULL
JL	NULL
,	NULL
Krange	NULL
!	NULL

l	NULL
MS	NULL
:	NULL
Identification	NULL
of	NULL
an	NULL
essential	NULL
site	NULL
for	NULL
transcriptional	NULL
activation	NULL
within	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
6	NULL
enhancer	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:5671	NULL
,	NULL
1991	NULL
18	NULL
.	NULL

Erickson	NULL
P	NULL
,	NULL
Gao	NULL
J	NULL
,	NULL
Chang	NULL
KS	NULL
,	NULL
Look	NULL
T	NULL
,	NULL
Whisenant	NULL
E	NULL
,	NULL
Rai-mondi	NULL
S	NULL
,	NULL
Lasher	NULL
R	NULL
,	NULL
Trujillo	NULL
J	NULL
,	NULL
Rowley	NULL
J	NULL
,	NULL
Drabkin	NULL
H	NULL
:	NULL
Identification	NULL
of	NULL
breakpoints	NULL
in	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
and	NULL
isolation	NULL
of	NULL
a	NULL
fusion	NULL
transcript	NULL
,	NULL
AMLI/ETO	NULL
,	NULL
with	NULL
similarity	NULL
to	NULL
Drosophila	NULL
segmentation	NULL
gene	NULL
,	NULL
runt	NULL
.	NULL

Blood	NULL
80:1825	NULL
,	NULL
1992	NULL
19	NULL
.	NULL

Ogawa	NULL
E	NULL
,	NULL
Inuzuka	NULL
M	NULL
,	NULL
Maruyama	NULL
M	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Naito-Fuji-moto	NULL
M	NULL
,	NULL
Ito	NULL
Y	NULL
,	NULL
Shigesada	NULL
K	NULL
:	NULL
Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
PEBp2/	NULL
,	NULL
the	NULL
heterodimeric	NULL
partner	NULL
of	NULL
a	NULL
novel	NULL
Drosophila	NULL
runt-related	NULL
DNA	NULL
binding	NULL
protein	NULL
PEBp2a	NULL
.	NULL

Virology	NULL
194:314	NULL
,	NULL
1993	NULL
20	NULL
.	NULL

Dauwerse	NULL
JG	NULL
,	NULL
Wessels	NULL
JW	NULL
,	NULL
Giles	NULL
RH	NULL
,	NULL
Wiegant	NULL
J	NULL
,	NULL
van	NULL
der	NULL
Reijden	NULL
BA	NULL
,	NULL
Fugazza	NULL
G	NULL
,	NULL
Jumelet	NULL
EA	NULL
,	NULL
Smit	NULL
E	NULL
,	NULL
Baas	NULL
F	NULL
,	NULL
Raap	NULL
AK	NULL
,	NULL
Hagemeijer	NULL
A	NULL
,	NULL
Beverstock	NULL
GC	NULL
,	NULL
van	NULL
Ommen	NULL
GJB	NULL
,	NULL
Breuning	NULL
MH	NULL
:	NULL
Cloning	NULL
the	NULL
breakpoint	NULL
cluster	NULL
region	NULL
of	NULL
the	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
.	NULL

Hum	NULL
Mol	NULL
Genet	NULL
2:1257	NULL
,	NULL
1993	NULL
21	NULL
.	NULL

Bitter	NULL
MA	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
,	NULL
Larson	NULL
RA	NULL
,	NULL
Rosner	NULL
MC	NULL
,	NULL
Golomb	NULL
HM	NULL
,	NULL
Rowley	NULL
JD	NULL
,	NULL
Vardiman	NULL
JW	NULL
:	NULL
A	NULL
morphological	NULL
and	NULL
cytochemical	NULL
study	NULL
of	NULL
acute	NULL
myelomonocytic	NULL
leukemia	NULL
with	NULL
abnormal	NULL
marrow	NULL
eosinophils	NULL
associated	NULL
with	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
.	NULL

Am	NULL
J	NULL
Clin	NULL
Pathol	NULL
81:733	NULL
,	NULL
1984	NULL
22	NULL
.	NULL

Mitelman	NULL
F	NULL
:	NULL
Guidelines	NULL
for	NULL
cancer	NULL
cytogenetics	NULL
,	NULL
supplement	NULL
to	NULL
an	NULL
international	NULL
system	NULL
for	NULL
human	NULL
cytogenetic	NULL
nomenclature	NULL
(	NULL
ISCN	NULL
)	NULL
.	NULL

Basel	NULL
,	NULL
Switzerland	NULL
,	NULL
Karger	NULL
Basel	NULL
,	NULL
1991	NULL
23	NULL
.	NULL

Chomezynski	NULL
P	NULL
,	NULL
Sacchi	NULL
N	NULL
:	NULL
Single	NULL
step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidium	NULL
isothiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
Biochem	NULL
162:156	NULL
,	NULL
1987	NULL
24	NULL
.	NULL

Izraeli	NULL
S	NULL
,	NULL
Lion	NULL
T	NULL
:	NULL
Multiprimer-PCR	NULL
for	NULL
screening	NULL
of	NULL
genetic	NULL
abnormalities	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukaemia	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
79:645	NULL
,	NULL
1991	NULL
25	NULL
.	NULL

Hunger	NULL
SP	NULL
,	NULL
Galili	NULL
N	NULL
,	NULL
Carroll	NULL
AJ	NULL
,	NULL
Crist	NULL
WM	NULL
,	NULL
Link	NULL
MP	NULL
,	NULL
Cleary	NULL
ML	NULL
:	NULL
The	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
(	NULL
q23	NULL
;	NULL
p13	NULL
)	NULL
results	NULL
in	NULL
consistent	NULL
fusion	NULL
of	NULL
E2A	NULL
and	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1322	NULL
PBX1	NULL
coding	NULL
sequences	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukemias	NULL
.	NULL

Blood	NULL
77.687	NULL
,	NULL
1991	NULL
26.	NULL
van	NULL
der	NULL
Reijden	NULL
BA	NULL
,	NULL
Dauwerse	NULL
JG	NULL
,	NULL
Wessels	NULL
JW	NULL
,	NULL
Beverstock	NULL
GC	NULL
,	NULL
Hagemeijer	NULL
A	NULL
,	NULL
van	NULL
Ommen	NULL
GJB	NULL
,	NULL
Breuning	NULL
MH	NULL
:	NULL
A	NULL
gene	NULL
for	NULL
a	NULL
myosin	NULL
peptide	NULL
is	NULL
disrupted	NULL
by	NULL
the	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
in	NULL
acute	NULL
non	NULL
lympheytic	NULL
leukemia	NULL
M4	NULL
Eo	NULL
.	NULL

Blood	NULL
82:2948	NULL
,	NULL
1993	NULL
27	NULL
.	NULL

Bitter	NULL
MA	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
,	NULL
Rowley	NULL
JD	NULL
,	NULL
Larson	NULL
RA	NULL
,	NULL
Golomb	NULL
HM	NULL
,	NULL
Vardiman	NULL
JW	NULL
:	NULL
Associations	NULL
between	NULL
morphology	NULL
,	NULL
karyotype	NULL
and	NULL
clinical	NULL
features	NULL
in	NULL
myeloid	NULL
leukemias	NULL
.	NULL

Hum	NULL
Pathol	NULL
18:211	NULL
,	NULL
1987	NULL
28	NULL
.	NULL

Cross	NULL
NCP	NULL
,	NULL
Lin	NULL
F	NULL
,	NULL
Goldman	NULL
JM	NULL
:	NULL
Appropriate	NULL
controls	NULL
for	NULL
reverse	NULL
transcription	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
$	NULL
7:218	NULL
,	NULL
1994	NULL
29	NULL
.	NULL

Grois	NULL
N	NULL
,	NULL
Nowotny	NULL
H	NULL
,	NULL
Ty	NULL
!	NULL

E	NULL
,	NULL
Krieger	NULL
O	NULL
,	NULL
Kier	NULL
P	NULL
,	NULL
Haas	NULL
OA	NULL
:	NULL
Is	NULL
trisomy	NULL
22	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
a	NULL
primary	NULL
abnormality	NULL
or	NULL
only	NULL
a	NULL
secondary	NULL
change	NULL
associated	NULL
with	NULL
inversion	NULL
16	NULL
?	NULL

Cancer	NULL
Genet	NULL
Cytogenet	NULL
43:119	NULL
,	NULL
1989	NULL
30	NULL
.	NULL

Mitelman	NULL
F	NULL
:	NULL
Catalogue	NULL
of	NULL
chromosome	NULL
aberrations	NULL
in	NULL
cancer	NULL
(	NULL
ed	NULL
4	NULL
)	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Liss	NULL
,	NULL
1991	NULL
,	NULL
p	NULL
2311	NULL
31	NULL
.	NULL

Morris	NULL
CM	NULL
,	NULL
Fitzgerald	NULL
PH	NULL
:	NULL
Ph-negative	NULL
chronic	NULL
myeloid	NULL
leukemia	NULL
:	NULL
The	NULL
nature	NULL
of	NULL
the	NULL
breakpoint	NULL
junctions	NULL
and	NULL
the	NULL
mechanism	NULL
of	NULL
ABL	NULL
transposition	NULL
.	NULL

Leuk	NULL
Lymphoma	NULL
6:277	NULL
,	NULL
1992	NULL
32	NULL
.	NULL

Izraeli	NULL
S	NULL
,	NULL
Janssen	NULL
JWG	NULL
,	NULL
Haas	NULL
OA	NULL
,	NULL
Harbott	NULL
J	NULL
,	NULL
Brok-Simoni	NULL
F	NULL
,	NULL
Walther	NULL
JU	NULL
,	NULL
Kovar	NULL
H	NULL
,	NULL
Henn	NULL
T	NULL
,	NULL
Ludwig	NULL
WD	NULL
,	NULL
Reiter	NULL
A	NULL
,	NULL
Rechavi	NULL
G	NULL
,	NULL
Bartram	NULL
CR	NULL
,	NULL
Gadner	NULL
H	NULL
,	NULL
Lion	NULL
T	NULL
:	NULL
Detection	NULL
and	NULL
clinical	NULL
relevance	NULL
of	NULL
genetic	NULL
abnormalities	NULL
in	NULL
pediatric	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
:	NULL
A	NULL
comparison	NULL
between	NULL
cytogenetic	NULL
and	NULL
polymerase	NULL
chain	NULL
reaction	NULL
analysis	NULL
.	NULL

Leukemia	NULL
7:671	NULL
,	NULL
1993	NULL
33	NULL
.	NULL

Maseki	NULL
N	NULL
,	NULL
Miyoshi	NULL
H	NULL
,	NULL
Shimizu	NULL
K	NULL
,	NULL
Homma	NULL
C	NULL
,	NULL
Ohki	NULL
M	NULL
,	NULL
Sa-kurai	NULL
M	NULL
,	NULL
Kaneko	NULL
Y	NULL
:	NULL
The	NULL
8	NULL
;	NULL
21	NULL
chromosome	NULL
translocation	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
is	NULL
always	NULL
detectable	NULL
by	NULL
molecular	NULL
analysis	NULL
using	NULL
AML1	NULL
.	NULL

Blood	NULL
81:1993	NULL
,	NULL
1993	NULL
34	NULL
.	NULL

Maruyama	NULL
F	NULL
,	NULL
Yang	NULL
P	NULL
,	NULL
Stass	NULL
SA	NULL
,	NULL
Cork	NULL
A	NULL
,	NULL
Freireich	NULL
EJ	NULL
,	NULL
Lee	NULL
M-S	NULL
,	NULL
Chang	NULL
K-S	NULL
:	NULL
Detection	NULL
of	NULL
the	NULL
AMLI/ETO	NULL
fusion	NULL
transcript	NULL
in	NULL
the	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
masked	NULL
translocation	NULL
in	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
.	NULL

Cancer	NULL
Res	NULL
53:4449	NULL
,	NULL
1993	NULL
35	NULL
.	NULL

Griesinger	NULL
F.	NULL
Elfers	NULL
H	NULL
,	NULL
Ludwig	NULL
WD	NULL
,	NULL
Falk	NULL
M	NULL
,	NULL
Rieder	NULL
H	NULL
,	NULL
Harbott	NULL
J	NULL
,	NULL
Lampert	NULL
F	NULL
,	NULL
Heinze	NULL
B	NULL
,	NULL
Hoelze	NULL
D	NULL
,	NULL
Thiel	NULL
E	NULL
,	NULL
Riehm	NULL
H	NULL
,	NULL
Wormann	NULL
POIREL	NULL
ET	NULL
AL	NULL
B	NULL
,	NULL
Fonatsch	NULL
C	NULL
,	NULL
Hiddemann	NULL
W	NULL
;	NULL
Detection	NULL
of	NULL
HRX-FEL	NULL
fusion	NULL
transcripts	NULL
in	NULL
pre-pre-B-ALL	NULL
with	NULL
and	NULL
without	NULL
cytogenetic	NULL
demonstration	NULL
of	NULL
t	NULL
(	NULL
4	NULL
;	NULL
11	NULL
)	NULL
.	NULL

Leukemia	NULL
8:542	NULL
,	NULL
1994	NULL
36	NULL
.	NULL

Caligiuri	NULL
MA	NULL
,	NULL
Schichman	NULL
SA	NULL
,	NULL
Strout	NULL
MP	NULL
,	NULL
Mrozek	NULL
K	NULL
,	NULL
Baer	NULL
MR	NULL
,	NULL
Frankel	NULL
SR	NULL
,	NULL
Barcos	NULL
M	NULL
,	NULL
Herzig	NULL
GP	NULL
,	NULL
Croce	NULL
CM	NULL
,	NULL
Bloomfield	NULL
CD	NULL
:	NULL
Molecular	NULL
rearrangement	NULL
of	NULL
the	NULL
ALL-1	NULL
gene	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
without	NULL
cytogenetic	NULL
evidence	NULL
of	NULL
11q23	NULL
chromosomal	NULL
trans-locations	NULL
.	NULL

Cancer	NULL
Res	NULL
54:370	NULL
,	NULL
1994	NULL
37	NULL
.	NULL

Berger	NULL
R	NULL
,	NULL
Bernheim	NULL
A	NULL
,	NULL
Daniel	NULL
MT	NULL
,	NULL
Valensi	NULL
F	NULL
,	NULL
Sigaux	NULL
F	NULL
,	NULL
Flandrin	NULL
G	NULL
:	NULL
Cytogenetic	NULL
studies	NULL
on	NULL
acute	NULL
myelomonocytic	NULL
leukemia	NULL
(	NULL
M4	NULL
)	NULL
with	NULL
eosinophilia	NULL
.	NULL

Leuk	NULL
Res	NULL
9:279	NULL
,	NULL
1985	NULL
38	NULL
.	NULL

Liu	NULL
P	NULL
,	NULL
Claxton	NULL
DF	NULL
,	NULL
Marlton	NULL
P	NULL
,	NULL
Hajra	NULL
A	NULL
,	NULL
Freedman	NULL
M	NULL
,	NULL
Chan-drasekharappa	NULL
SC	NULL
,	NULL
Yanagisawa	NULL
K	NULL
,	NULL
Stallings	NULL
RL	NULL
,	NULL
Collins	NULL
FS	NULL
,	NULL
Siciliano	NULL
MJ	NULL
:	NULL
Identification	NULL
of	NULL
yeast	NULL
artificial	NULL
chromosomes	NULL
containing	NULL
the	NULL
inversion	NULL
16p-arm	NULL
breakpoint	NULL
associated	NULL
with	NULL
acute	NULL
myelomonocytic	NULL
leukemia	NULL
.	NULL

Blood	NULL
82:716	NULL
,	NULL
1993	NULL
39	NULL
.	NULL

Lake	NULL
RA	NULL
,	NULL
Wotton	NULL
D	NULL
,	NULL
Owen	NULL
MJ	NULL
:	NULL
A	NULL
3	NULL
``	NULL
transcriptional	NULL
enhancer	NULL
regulates	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
CD2	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
9:3129	NULL
,	NULL
1990	NULL
40	NULL
.	NULL

Clevers	NULL
H	NULL
,	NULL
Lonberg	NULL
N	NULL
,	NULL
Dunlap	NULL
S	NULL
,	NULL
Lacy	NULL
E	NULL
,	NULL
Terhorst	NULL
C	NULL
:	NULL
An	NULL
enhancer	NULL
located	NULL
in	NULL
a	NULL
CpG-island	NULL
3	NULL
'	NULL
to	NULL
the	NULL
TCR/CD3-e	NULL
gene	NULL
confers	NULL
T	NULL
lymphocyte-specificity	NULL
to	NULL
its	NULL
promotor	NULL
.	NULL

EMBO	NULL
J	NULL
8:2527	NULL
,	NULL
1989	NULL
41	NULL
.	NULL

Troussard	NULL
X	NULL
,	NULL
Galateau	NULL
F	NULL
,	NULL
Gaulard	NULL
P	NULL
,	NULL
Reman	NULL
O	NULL
,	NULL
Henni	NULL
T	NULL
,	NULL
Le	NULL
Couedic	NULL
JP	NULL
,	NULL
Leporrier	NULL
M	NULL
:	NULL
Lymphomatoid	NULL
granulomatosis	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
acute	NULL
myeloblastic	NULL
leukemia	NULL
in	NULL
remission	NULL
.	NULL

Cancer	NULL
65:107	NULL
,	NULL
1990	NULL
42	NULL
.	NULL

Cogan	NULL
E	NULL
,	NULL
Schandene	NULL
L	NULL
,	NULL
Crusiaux	NULL
A	NULL
,	NULL
Cochaux	NULL
P	NULL
,	NULL
Velu	NULL
T	NULL
,	NULL
Goldman	NULL
M	NULL
:	NULL
Brief	NULL
report	NULL
:	NULL
Clonal	NULL
proliferation	NULL
of	NULL
type	NULL
2	NULL
helper	NULL
T	NULL
cells	NULL
in	NULL
a	NULL
man	NULL
with	NULL
hypereosinophilic	NULL
syndrome	NULL
.	NULL

N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
330:535	NULL
,	NULL
1994	NULL
43	NULL
.	NULL

Raghavachar	NULL
AA	NULL
,	NULL
Fleischer	NULL
S	NULL
,	NULL
Frickhofen	NULL
N	NULL
,	NULL
Heimpel	NULL
H	NULL
,	NULL
Fleischer	NULL
B	NULL
:	NULL
T	NULL
lymphocyte	NULL
control	NULL
of	NULL
human	NULL
eosinophilic	NULL
granulo-poiesis	NULL
:	NULL
Clonal	NULL
analysis	NULL
in	NULL
an	NULL
idiopathic	NULL
hypereosinophilic	NULL
syndrome	NULL
.	NULL

J	NULL
Immunol	NULL
139:3753	NULL
,	NULL
1987	NULL
44	NULL
.	NULL

Nuchprayoon	NULL
I	NULL
,	NULL
Meyers	NULL
S	NULL
,	NULL
Scott	NULL
LM	NULL
,	NULL
Suzow	NULL
J	NULL
,	NULL
Hiebert	NULL
S	NULL
,	NULL
Friedman	NULL
AD	NULL
:	NULL
PEBP2/CBF	NULL
,	NULL
the	NULL
murine	NULL
homolog	NULL
of	NULL
the	NULL
human	NULL
myeloid	NULL
AML1	NULL
and	NULL
PEB2A/CBFS	NULL
proto-oncoproteins	NULL
,	NULL
regulates	NULL
the	NULL
murine	NULL
myeloperoxidase	NULL
and	NULL
neutrophil	NULL
elastase	NULL
genes	NULL
in	NULL
immature	NULL
myeloid	NULL
cells	NULL
.	NULL

Moll	NULL
Cell	NULL
Biol	NULL
14:5558	NULL
,	NULL
1994	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blOOd	NULL
1995	NULL
85	NULL
:	NULL
1313-1322	NULL
Detection	NULL
of	NULL
the	NULL
chromosome	NULL
16	NULL
CBF	NULL
beta-MYH11	NULL
fusion	NULL
transcript	NULL
in	NULL
myelomonocytic	NULL
leukemias	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
©1004	NULL
@	NULL
207	NULL
H	NULL
Poirel	NULL
,	NULL
|	NULL
Radford-Weiss	NULL
,	NULL
K	NULL
Rack	NULL
,	NULL
X	NULL
Troussard	NULL
,	NULL
A	NULL
Veil	NULL
,	NULL
F	NULL
Valensi	NULL
,	NULL
F	NULL
Picard	NULL
,	NULL
M	NULL
Guesnu	NULL
,	NULL
D	NULL
Leboeuf	NULL
and	NULL
J	NULL
Melle	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/85/5/1313.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

